Over a week ago |
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 05/24/23
- XPeng sees Q2 total revenue RMB 4.5B-4.7B
- 05/01/23
- XPeng delivers 7,079 Smart EVs in April
- 04/19/23
- XPeng falls -12.0%
- 04/19/23
- XPeng falls -9.4%
- 03/22/23
- Petco falls 7% to $9.44 after Q4 results, FY23 guidance
- 03/22/23
- Petco expects to make $100M in principal payments on term loan in FY23
- 03/22/23
- Petco sees FY23 CapEx $225M-$250M
- $31.34 /
+4.675 (+17.54%) - 03/06/23
- Urban Outfitters COO Conforti sells 42,000 common shares
- 02/28/23
- Urban Outfitters says Q1 revenue growth could be 'similar to Q4'
- 02/28/23
- Urban Outfitters reports comparable retail segment sales up 3%
- 01/09/23
- Urban Outfitters reports holiday sales increased 2.3%
- 05/23/23
- Toll Brothers sees FY23 deliveries 8,900-9,500
- 05/23/23
- Toll Brothers sees Q3 deliveries 2,350-2,450
- 04/27/23
- Pending home sales decreased 5.2% in March amid limited supply, NAR says
- 03/15/23
- Toll Brothers Apartment Living breaks ground on Vermeer
- $131.37 /
-15.59 (-10.61%) - 05/24/23
- Sarepta to remain in quiet period during FDA BLA review for SRP-9001
- 05/24/23
- Sarepta: FDA working towards accelerated approval for SRP-9001 for DMD treatment
- 05/15/23
- Sarepta jumps 26% to $150.96 following positive FDA panel vote
- 05/13/23
- Sarepta confirms FDA panel vote in favor of DMD gene therapy
- 03/01/23
- Einhorn says not invested long in artificial intelligence companies
- 12/14/22
- SEC proposes rules to enhance competition for retail order flow execution
- 04/30/23
- Fly Intel: Top five weekend stock stories
- 04/25/23
- Sherwin-Williams sees Q2 net sales up or down low-single digit %
- 04/19/23
- Sherwin-Williams to divest China paint business to Akzo Nobel N.V.
- 04/19/23
- Sherwin-Williams signs purchase agreement with Akzo Nobel N.V.
- 05/04/23
- Shopify rises 27.3%
- 05/04/23
- Shopify rises 22.3%
- 05/04/23
- Shopify rises 19.0%
- 05/04/23
- Shopify says 'will be smaller by about 20%' after today
- $46.94 /
-11.51 (-19.69%) - 05/23/23
- PTC Therapeutics down 21% after announced gene therapy program discontinuation
- 05/23/23
- PTC Therapeutics terminates employment of CFO Emily Hill
- 05/23/23
- PTC Therapeutics to reduce workforce by about 8%
- 05/23/23
- PTC's MOVE-FA trial of vatiquinone did not meet its primary endpoint
- $18.69 /
-5.045 (-21.26%) - 05/24/23
- Children's Place plans to close 80-100 stores in 2023
- 05/10/23
- Children's Place announces election of all director candidates
- 02/06/23
- Children's Place falls 10% to $42.08 after lowering Q4 outlook
- $204.38 /
+14.465 (+7.62%) - 05/23/23
- Palo Alto Networks expects supply chains to normalize exiting FY23
- 05/23/23
- Palo Alto Networks says deal scrutiny has increased
- 05/23/23
- Palo Alto Networks sees FY23 adjusted free cash flow margin 37.5%-38.5%
- 04/25/23
- Accenture, Palo Alto Networks collaborate to deliver SASE solutions
- 04/27/23
- Organogenesis President, CEO Gillheeney, Sr. elected as chair of the board
- 03/27/23
- Organogenesis applauds findings from the Office of Inspector General
- 03/20/23
- S&P announces changes to S&P 400, 600 indices at open on 3/20
- 05/23/23
- Nvidia integrating AI Enterprise software into Microsoft Azure Machine Learning
- 05/23/23
- Nvidia integrating AI Enterprise software into Microsoft Azure Machine Learning
- 05/23/23
- Dell Technologies, Nvidia to partner around on-premises generative AI
- 05/22/23
- Nvidia exec sells $7.04M in common stock
- 05/23/23
- Shutterstock to acquire GIPHY from Meta Platforms for $53M
- 05/23/23
- Shutterstock to acquire GIPHY from Meta Platforms for $53M
- 05/22/23
- Meta Platforms says Bombyx being licensed for product development
- 05/22/23
- WhatsApp introduces 'Edit' feature for sent messages
- 05/24/23
- Kohl's rises 10.6%
- 05/24/23
- Kohl's rises 14.7%
- 05/19/23
- Kohl's falls -9.6%
- 05/19/23
- Foot Locker names Mike Baughn as new CFO
- $416.02 /
-34.745 (-7.71%) - 05/23/23
- Intuit sees average revenue per return up 12%
- 05/15/23
- Tiger Global buys TSMC, exits AppLovin in Q1
- 05/04/23
- Intuit names CEOs of LinkedIn, Zoom Video to board
- 02/23/23
- Intuit names Sandeep Singh Aujla as new CFO
- $212.74 /
+8.215 (+4.02%) - 05/18/23
- Illumina board chair issues letter, urges shareholders to vote for all nominees
- 05/15/23
- Icahn bought Illumina in Q1, sold shares of Herc and Newell
- 05/15/23
- Icahn says Illumina shareholders 'clearly want more change'
- 05/15/23
- Illumina board urges shareholders to vote the WHITE proxy card
IART Integra LifeSciences - 05/23/23
- Integra LifeSciences falls 15% after product recall, Q2 guidance cut
- 05/23/23
- Integra LifeSciences voluntary recalls all products made in Boston plant
- 01/25/23
- Integra LifeSciences confirms Carrie Anderson to step down as CFO
- 01/25/23
- Campbell Soup names Carrie Anderson as new CFO
- 05/17/23
- ECB fines Goldman EUR 6.3M for misreporting capital needs
- 05/16/23
- National Western Life to explore strategic alternatives
- 05/11/23
- FDIC proposes rule for special assessment on big banks for cost recovery
- 05/11/23
- FDIC proposes largest banks to pay more to replenish Deposit Insurance Fund
- 05/24/23
- Jana to nominate four to Freshpet board, citing 'pattern of missteps'
- 05/17/23
- Freshpet appoints Walter George as new independent chair
- 05/15/23
- Jana exited Encompass Health during Q1, bought more FIS
- 03/22/23
- Freshpet, Petco announce delivery partnership
- 05/08/23
- Camping World intends to acquire I-90 RV, as entry ino Montana RV market
- 05/03/23
- Camping World rises 11.8%
- 04/17/23
- Camping World increases California location count with All Seasons RV Yuba City
- 04/13/23
- Camping World to acquire All Seasons RV in Bend, Oregon
- 05/24/23
- CMA provisionally finds five banks broke competition law on U.K. bonds
- 05/24/23
- Citi to resume 'modest' level of share buybacks this quarter
- 05/24/23
- Citi to pursue IPO of Banco Nacional de Mexico business
- 05/24/23
- Citi to pursue IPO of Mexico business Banamex
- 05/24/23
- Avid Technology jumps 13% to $23.20 after Reuters says company exploring sale
- 02/16/23
- Avid Technology announces new Pro Tools Scripting SDK
- 11/30/22
- TV MIDTVEST expands strategic relationship with Avid Technology
- 11/28/22
- Avid Technology appoints Deb Sanders as CCO
- $30.18 /
+7.105 (+30.80%) - 05/24/23
- Abercrombie & Fitch rises 26.0%
- 05/24/23
- Abercrombie & Fitch rises 20.7%
- 05/24/23
- Abercrombie & Fitch rises 18.1%
- 03/30/23
- Abercrombie & Fitch launches co-designed collection with Tia Booth
- $173.26 /
-14.59 (-7.77%) - 05/24/23
- Microchip reiterates prior guidance on backlog confidence
- 05/24/23
- Analog falls 6% after Q3 EPS view and expectations of moderating revenue
- 05/24/23
- Analog Devices: Longer term focus for data processing shifting 'to the edge'
- 05/24/23
- Analog Devices sees 2H revenue to moderate amid 'continued economic uncertainty'
- 02/16/23
- Accolade announces Michael Hilton to join board of directors
- 02/06/23
- Cathie Wood's ARK Investment bought 313.7K shares of Accolade today
- 05/23/23
- Broadcom up 2% after Apple announces 'multibillion-dollar' supply deal
- 05/23/23
- Broadcom reports two separate multi-year statements of work with Apple
- 05/23/23
- Apple reports 'multibillion-dollar' deal with Broadcom for U.S.-made components
- 05/22/23
- United Airlines to support Live Activities for iPhone
- 03/22/23
- Senators Scott, Warren unveil bipartisan Fed oversight legislation
- 03/01/23
- Einhorn says investors should be 'bearish on stocks and bullish on inflation'
- $416.02 /
-34.745 (-7.71%) - 05/24/23 Piper Sandler
- Intuit price target lowered to $497 from $510 at Piper Sandler
- 05/24/23 BMO Capital
- Intuit price target raised to $485 from $462 at BMO Capital
- 05/24/23 BofA
- Intuit price target raised to $500 from $485 at BofA
- 05/24/23 Morgan Stanley
- Intuit price target raised to $525 from $520 at Morgan Stanley
- 05/25/23 Keefe Bruyette
- Citi price target lowered to $48 from $50 at Keefe Bruyette
- 05/24/23 Credit Suisse
- Citi price target lowered to $50 from $54 at Credit Suisse
- 05/24/23 Morgan Stanley
- Grupo Mexico upgraded to Overweight from Equal Weight at Morgan Stanley
- 05/12/23 Evercore ISI
- Citi price target lowered to $50 from $53 at Evercore ISI
- $131.37 /
-15.59 (-10.61%) - 05/24/23 Credit Suisse
- Sarepta price target lowered to $141 from $151 at Credit Suisse
- 05/24/23 Citi
- Sarepta may trade 'towards $120s,' should be bought on weakness, says Citi
- 05/16/23 RBC Capital
- Sarepta price target raised to $218 from $197 at RBC Capital
- 05/15/23 BofA
- Sarepta price target raised to $176 from $164 at BofA
- 05/09/23 Baird
- Freshpet price target raised to $80 from $75 at Baird
- 02/28/23 Truist
- Freshpet price target raised to $55 from $40 at Truist
- 02/28/23 Baird
- Freshpet price target raised to $75 from $70 at Baird
- 02/28/23 Credit Suisse
- Freshpet price target raised to $65 from $60 at Credit Suisse
- 05/24/23 JPMorgan
- JPMorgan says odds of no debt ceiling deal 25% and rising
- 05/23/23 JPMorgan
- JPMorgan strategist raises cash allocation on 'misplaced' stock rally
- 04/17/23 JPMorgan
- JPMorgan 'heavily favors cash' after 'irrational' stock market rally
- 03/27/23 JPMorgan
- JPMorgan strategist says Q1 likely high point for equities this year
SPY SPDR S&P 500 ETF Trust - 05/24/23 Exane BNP Paribas
- Exane downgrades Shopify to Underperform on small business exposure
- 05/24/23 Exane BNP Paribas
- Shopify downgraded to Underperform from Neutral at Exane BNP Paribas
- 05/23/23 BofA
- Global-e Online price target raised to $42 from $36 at BofA
- 05/09/23 Loop Capital
- Shopify price target raised to $69 from $60 at Loop Capital
- 05/24/23 BMO Capital
- Camping World upgraded to Outperform from Market Perform at BMO Capital
- 05/04/23 Raymond James
- Camping World price target lowered to $27 from $28 at Raymond James
- 04/18/23 KeyBanc
- Camping World coverage transitioned with an Overweight at KeyBanc
- 02/23/23 BMO Capital
- Camping World price target lowered to $26 from $30 at BMO Capital
- 05/24/23 BofA
- BofA upgrades Accolade to Buy on 'highly appealing' risk/reward
- 05/24/23 BofA
- Accolade upgraded to Buy from Neutral at BofA
- 05/09/23 Wells Fargo
- Wells says high-teen revenue CAGR 'likely more realistic' for Accolade
- 05/02/23 Piper Sandler
- Accolade should be bought into investor day, says Piper Sandler
- 05/24/23 Jefferies
- Sherwin-Williams upgraded to Buy from Hold at Jefferies
- 04/27/23 Deutsche Bank
- Sherwin-Williams price target raised to $265 from $260 at Deutsche Bank
- 04/27/23 Barclays
- Sherwin-Williams price target raised to $240 from $220 at Barclays
- 04/26/23 BMO Capital
- Sherwin-Williams price target raised to $253 from $231 at BMO Capital
IART Integra LifeSciences - 05/24/23 JPMorgan
- Integra LifeSciences downgraded to Underweight from Neutral at JPMorgan
- 05/23/23 BTIG
- Organogenesis upgraded to Buy from Neutral at BTIG
- 05/23/23 Citi
- Citi downgrades Integra to Sell, sees further guidance cuts
- 05/23/23 Citi
- Integra LifeSciences downgraded to Sell from Neutral at Citi
- 05/23/23 Piper Sandler
- Meta's AI initiatives could drive revenue recapture, says Piper Sandler
- 05/23/23 Citi
- Citi sees minimal risk to Meta Platforms after E.U. data fine
- 05/22/23 Evercore ISI
- Meta, Spotify, Zillow removed from 'Tactical Outperform' list at Evercore ISI
- 05/19/23 Roth MKM
- Meta Platforms' capex may decline in 2023-2024, says Roth MKM
- 05/25/23 BofA
- Nvidia price target raised to $450 from $340 at BofA
- 05/25/23 Evercore ISI
- Nvidia price target raised to $500 from $320 at Evercore ISI
- 05/25/23 Wedbush
- Wedbush upgrades Nvidia to Outperform following quarterly results
- 05/25/23 Jefferies
- Nvidia price target raised to $472 from $300 at Jefferies
- $212.74 /
+8.215 (+4.02%) - 04/26/23 Stifel
- Illumina price target raised to $265 from $235 at Stifel
- 04/26/23 Baird
- Illumina price target raised to $229 from $224 at Baird
- 03/13/23 Piper Sandler
- Piper agrees with Icahn, says Illumina base business undervalued
- 02/14/23 UBS
- Illumina price target lowered to $240 from $255 at UBS
- 03/06/23 Truist
- Avid Technology initiated with a Buy at Truist
- 08/03/22 B. Riley
- Avid Technology price target lowered to $34 from $45 at B. Riley
- 07/11/22 Rosenblatt
- Avid Technology initiated with a Neutral at Rosenblatt
- 07/06/22 JPMorgan
- Avid Technology initiated with an Overweight at JPMorgan
- 05/23/23 BofA
- Broadcom price target raised to $800 from $725 at BofA
- 05/22/23 Loop Capital
- Loop downgrades Apple on 'material downside risk' to guidance
- 05/22/23 Loop Capital
- Apple downgraded to Hold from Buy at Loop Capital
- 05/12/23 Citi
- State Street, BNY Mellon hurt most from FDIC proposal, says Citi
- 04/19/23 BMO Capital
- Goldman Sachs price target lowered to $414 from $429 at BMO Capital
- 04/19/23 Morgan Stanley
- Goldman Sachs price target raised to $337 from $329 at Morgan Stanley
- 04/19/23 RBC Capital
- Goldman Sachs price target raised to $375 from $339 at RBC Capital
- 03/12/23 BTIG
- BTIG finds medical technology stocks with exposure with SVB
- 11/10/22 BTIG
- Organogenesis downgraded to Neutral from Buy at BTIG
- 08/10/22 Oppenheimer
- Oppenheimer downgrades Organogenesis to Perform on lowered guidance
- $31.34 /
+4.675 (+17.54%) - 05/24/23 Deutsche Bank
- Urban Outfitters price target raised to $29 from $26 at Deutsche Bank
- 05/24/23 BMO Capital
- Urban Outfitters price target raised to $31 from $25 at BMO Capital
- 05/24/23 Baird
- Urban Outfitters price target raised to $32 from $30 at Baird
- $46.94 /
-11.51 (-19.69%) - 05/24/23 TD Cowen
- PTC Therapeutics price target lowered to $40 from $47 at TD Cowen
- 05/24/23 Credit Suisse
- PTC Therapeutics price target lowered to $50 from $55 at Credit Suisse
- 05/24/23 Citi
- PTC Therapeutics price target lowered to $63 from $70 at Citi
- 05/24/23 Barclays
- PTC Therapeutics price target lowered to $48 from $57 at Barclays
- $18.69 /
-5.045 (-21.26%) - 05/25/23 UBS
- Children's Place price target lowered to $20 from $40 at UBS
- 05/11/23 B. Riley
- Children's Place initiated with a Buy at B. Riley
- 03/29/23 UBS
- Children's Place price target lowered to $40 from $45 at UBS
- 02/07/23 Telsey Advisory
- Children's Place downgraded to Market Perform from Outperform at Telsey
- 04/28/23 Gordon Haskett
- Petco initiated with a Hold, $10 target at Gordon Haskett
- 04/28/23 Gordon Haskett
- Petco initiated with a Hold at Gordon Haskett
- 04/14/23 Needham
- Petco price target lowered to $15 from $20 at Needham
- 03/29/23 BofA
- Petco price target lowered to $14.50 from $18 at BofA
- 05/25/23 Barclays
- XPeng downgraded to Underweight from Equal Weight at Barclays
- 04/25/23 Jefferies
- XPeng upgraded to Hold from Underperform at Jefferies
- 03/30/23 Barclays
- Barclays stays on sidelines after 'weak' results from XPeng
- 03/29/23 Morgan Stanley
- Other EV startups may need to consider actions like Lucid, says Morgan Stanley
- $204.38 /
+14.465 (+7.62%) - 05/24/23 Deutsche Bank
- Palo Alto Networks price target raised to $225 from $210 at Deutsche Bank
- 05/24/23 Loop Capital
- Palo Alto Networks price target raised to $240 from $225 at Loop Capital
- 05/24/23 Baird
- Palo Alto Networks price target raised to $235 from $230 at Baird
- 05/24/23 Evercore ISI
- Palo Alto Networks price target raised to $240 from $215 at Evercore ISI
- 05/25/23 TD Cowen
- Kohl's price target lowered to $23 from $31 at TD Cowen
- 05/25/23 Baird
- Kohl's price target lowered to $30 from $35 at Baird
- 05/25/23 Citi
- Kohl's price target raised to $20 from $19 at Citi
- 05/16/23 Citi
- Kohl's price target lowered to $19 from $26 at Citi
- 05/25/23 Zelman
- Toll Brothers upgraded to Buy from Hold at Zelman
- 05/25/23 RBC Capital
- Toll Brothers upgraded to Outperform from Sector Perform at RBC Capital
- 05/24/23 Credit Suisse
- Toll Brothers price target raised to $73 from $63 at Credit Suisse
- 02/23/23 BofA
- Toll Brothers price target raised to $70 from $68 at BofA
- $30.18 /
+7.105 (+30.80%) - 05/25/23 Citi
- Abercrombie & Fitch price target raised to $33 from $24 at Citi
- 05/25/23 UBS
- Abercrombie & Fitch price target raised to $32 from $28 at UBS
- 05/18/23 Citi
- Abercrombie & Fitch price target lowered to $24 from $32 at Citi
- 05/09/23 Jefferies
- Abercrombie & Fitch price target lowered to $30 from $35 at Jefferies
- $173.26 /
-14.59 (-7.77%) - 05/25/23 TD Cowen
- Analog Devices price target lowered to $200 from $225 at TD Cowen
- 05/25/23 Wells Fargo
- Analog Devices price target lowered to $185 from $190 at Wells Fargo
- 05/25/23 Bernstein
- Analog Devices price target lowered to $210 from $220 at Bernstein
- 05/25/23 Oppenheimer
- Analog Devices price target lowered to $215 from $230 at Oppenheimer
- 05/24/23
- XPeng reports Q1 EPS (37c), consensus (26c)
- 03/17/23
- XPeng sees Q1 revenue down 43.7%-46.3%, consensus $882.99M
- 03/17/23
- XPeng reports Q4 adjusted EPS (37c), consensus (36c)
- 11/30/22
- XPeng sees Q4 revenue RMB 4.8B-RMB 5.1B
- 05/24/23
- Petco backs FY23 adjusted EPS view 40c-48c, consensus 45c
- 05/24/23
- Petco reports Q1 adjusted EPS 6c, consensus 5c
- 05/23/23
- Notable companies reporting before tomorrow's open
- $31.34 /
+4.675 (+17.54%) - 05/23/23
- Urban Outfitters reports Q1 EPS 56c, consensus 35c
- 02/28/23
- Urban Outfitters reports Q4 EPS 34c, consensus 38c
- 05/23/23
- Toll Brothers reports Q2 EPS $2.85, consensus $1.91
- 02/21/23
- Toll Brothers affirms FY23 EPS view of $8.00-$9.00, consensus $8.41
- 02/21/23
- Toll Brothers reports Q1 EPS $1.70, consensus $1.41
- $131.37 /
-15.59 (-10.61%) - 05/02/23
- Sarepta Therapeutics reports Q1 adjusted EPS (97c), consensus ($1.38)
- 02/28/23
- Sarepta reports Q4 EPS ($1.24), consensus ($1.35)
- 01/09/23
- Sarepta expects to exceed FY22 guidance for net product revenues
- 04/25/23
- Sherwin-Williams sees FY23 adjusted EPS $7.95-$8.65, consensus $8.48
- 04/25/23
- Sherwin-Williams reports Q1 adjusted EPS $2.04, consensus $1.78
- 04/24/23
- Notable companies reporting before tomorrow's open
- 05/04/23
- Shopify sees Q2 revenue growth rate similar to Q1
- 05/04/23
- Shopify reports Q1 adjusted EPS 1c, consensus (4c)
- 02/15/23
- Shopify sees Q1 revenue growth in high teens percentages
- 02/15/23
- Shopify reports Q4 adjusted EPS 7c, consensus (1c)
- $46.94 /
-11.51 (-19.69%) - 04/27/23
- PTC Therapeutics backs 2023 revenue view $940M-$1.0B, consensus $866.89M
- 04/27/23
- PTC Therapeutics reports Q1 EPS ($1.88), consensus ($1.39)
- 02/21/23
- PTC Therapeutics backs FY23 revenue view $940M-$1B, consensus $898.56M
- 02/21/23
- PTC Therapeutics reports Q4 EPS ($2.35), consensus ($1.59)
- $18.69 /
-5.045 (-21.26%) - 05/24/23
- Children's Place sees 2023 adjusted EPS $1.00-$1.50, consensus $2.15
- 05/24/23
- Children's Place sees Q2 adjusted EPS ($2.15)-($2.20), consensus ($1.56)
- 05/24/23
- Children's Place reports Q1 adjusted EPS ($2.00), consensus ($1.83)
- 03/16/23
- Children's Place sees FY23 adjusted EPS $2.50-$3.00, consensus $3.35
- $204.38 /
+14.465 (+7.62%) - 05/23/23
- Palo Alto Networks raises FY23 adjusted EPS view to $4.25-$4.29 from $3.97-$4.03
- 05/23/23
- Palo Alto Networks sees Q4 adjusted EPS $1.26-$1.30, consensus $1.20
- 05/23/23
- Palo Alto Networks reports Q3 adjusted EPS $1.10, consensus 93c
- 05/10/23
- Organogenesis reports Q1 EPS (2c), consensus (2c)
- 05/24/23
- Nvidia jumps 15% to $350.53 after Q1 beat, better than expected guidance
- 05/24/23
- Nvidia sees Q2 revenue $11B +/- 2%, consensus 7.15B
- 05/24/23
- Nvidia sees Q2 revenue $11B, +/- 2%, consensus $7.15B
- 05/24/23
- Nvidia reports Q1 EPS $1.09, consensus 92c
- 05/21/23
- Fly Intel: Top five weekend stock stories
- 04/26/23
- Meta Platforms sees Q2 revenue $29.5B-$32B, consensus $29.48B
- 04/26/23
- Meta Platforms reports Q1 EPS $2.20, consensus $2.53
- 04/26/23
- Notable companies reporting after market close
- 05/24/23
- Kohl's backs FY23 EPS $2.10-$2.70 view, consensus $2.32
- 05/24/23
- Kohl's reports Q1 EPS 13c, consensus (42c)
- $416.02 /
-34.745 (-7.71%) - 05/23/23
- Intuit sees Q4 EPS $1.43-$1.48, consensus $1.51
- 05/23/23
- Intuit sees FY23 EPS $14.20-$14.25, consensus $13.83
- 05/23/23
- Intuit reports Q3 EPS $8.92, consensus $8.48
- 05/23/23
- Notable companies reporting after market close
- $212.74 /
+8.215 (+4.02%) - 04/25/23
- Illumina reports Q1 non-GAAP EPS 8c, consensus 2c
- 04/25/23
- Illumina sees FY23 non GAAP EPS $1.25-$1.50, consensus $1.41
- 04/25/23
- Illumina reports Q1 EPS 2c, consensus 2c
- 04/25/23
- Notable companies reporting after market close
IART Integra LifeSciences - 05/23/23
- Integra LifeSciences sees Q2 adjusted EPS 55c-59c, consensus 77c
- 04/26/23
- Integra LifeSciences sees Q2 adjusted EPS 75c-79c, consensus 85c
- 04/26/23
- Integra LifeSciences backs FY23 adjusted EPS view $3.43-$3.51, consensus $3.48
- 04/26/23
- Integra LifeSciences reports Q1 adjusted EPS 74c, consensus 74c
- 04/18/23
- Goldman Sachs reports Q1 EPS $8.79, consensus $8.10
- 04/17/23
- Notable companies reporting before tomorrow's open
- 01/17/23
- Goldman Sachs reports Q4 EPS $3.32, consensus $5.48
- 05/08/23
- Freshpet sees 2023 revenue $750M, consensus $752.3M
- 05/08/23
- Freshpet reports Q1 EPS (52c), consensus (44c)
- 02/27/23
- Freshpet sees 2023 net sales about $750M, consensus $755.01M
- 02/27/23
- Freshpet reports Q4 EPS (6c), consensus (9c)
- 05/02/23
- Camping World reports Q1 EPS 5c, consensus (6c)
- 02/21/23
- Camping World reports Q4 EPS (20c), consensus 1c
- 04/14/23
- Citi reports Q1 EPS $2.19, consensus $1.67
- 04/13/23
- Notable companies reporting before tomorrow's open
- 01/13/23
- Citi sees Q1 revenues up mid-single digits, consensus $19.37B
- 01/13/23
- Citi sees FY23 revenue $78B-$79B, consensus $76.15B
- 05/04/23
- Avid Technology sees FY23 EPS $1.53-$1.75, consensus $1.65
- 05/04/23
- Avid Technology sees Q2 EPS 15c-30c, consensus 32c
- 05/04/23
- Avid Technology reports Q1 EPS 15c, consensus 25c
- 03/01/23
- Avid Technology sees FY23 EPS $1.53-$1.75, consensus $1.63
- $30.18 /
+7.105 (+30.80%) - 05/24/23
- Abercrombie & Fitch sees Q2 revenue up 4%-6% vs. 2Q22, consensus $813.27M
- 05/24/23
- Abercrombie & Fitch raises 2023 revenue growth view 2%-4% from 1%-3%
- 05/24/23
- Abercrombie & Fitch reports Q1 adjusted EPS 39c, consensus (5c)
- 03/01/23
- Abercrombie & Fitch sees Q1 revenue flat vs. 1Q22, consensus $795.74M
- $173.26 /
-14.59 (-7.77%) - 05/24/23
- Analog Devices sees Q3 EPS $2.42-$2.62 , consensus $2.65
- 05/24/23
- Analog Devices reports Q2 EPS $2.83, consensus $2.75
- 04/27/23
- Accolade sees FY24 revenue $410M, consensus $409.94M
- 04/27/23
- Accolade sees Q1 revenue $89M-$91M, consensus $94.51M
- 04/27/23
- Accolade reports Q4 EPS (42c), consensus (42c)
- 01/09/23
- Accolade guides initial FY24 revenue around $410M, consensus $405.4M
- 05/04/23
- Apple sees Q3 revenue growth 'similar' to Q2, consensus $84.71B
- 05/04/23
- Apple sees Q3 revenue 'similar' to Q2, consensus $84.71B
- 05/04/23
- Apple reports Q2 EPS $1.52, consensus $1.43
- 04/16/23
- Xpeng aims to cut costs with new vehicle manufacturing platform, Reuters says
- 01/17/23
- XPeng follows Tesla with price cuts in China, Reuters reports
- 01/16/23
- EVs made up 10% of all new cars sold last year, WSJ reports
- 05/10/23
- Luxury home prices drop for 1st time since financial crisis,Markets Insider says
- 12/17/22
- Amazon, Google among Barron's 10 favorite stocks for 2023
- 12/03/22
- Housing stocks are down, but there are signs of rebound, Barron's says
- $131.37 /
-15.59 (-10.61%) - 04/13/23
- Sarepta sinks after STAT says FDA leaned against gene therapy approval
- 03/20/23
- Treasury considering expanding FDIC coverage to all deposits, Bloomberg reports
- 03/14/23
- Fed may extend tougher capital restrictions to midsize banks, WSJ says
- 04/30/23
- Goldman, Target among dividend growth stocks for slowing economy, Barron's says
- 01/27/23
- Shopify CTO Allan Leinwand to depart company, Insider reports
- 01/03/23
- Shopify Audiences a 'key focus' for company, FT reports
- $204.38 /
+14.465 (+7.62%) - 03/15/23
- Microsoft says Russia's spring offensive may include new cyberattacks, NYT says
- 01/06/23
- White House to unveil cybersecurity strategy, Washington Post reports
- 05/24/23
- Nvidia CEO says chip wars risk 'enormous damage,' FT reports
- 05/18/23
- Chipmakers plan expansion, partnerships in Japan, FT reports
- 05/10/23
- European Union to clear Activision buyout next week, Reuters reports
- 05/24/23
- Meta Platforms starts next round of layoffs, CNBC reports
- 05/24/23
- EU court dismisses Meta's challenge to hand over data, Bloomberg reports
- 05/23/23
- White House wants workers opinion on employers use of AI, Reuters reports
- 05/22/23
- Meta Platforms has potential for further job cuts, CNBC says
- 01/25/23
- Interim Kohl's CEO Kingsbury in late-stage talks to be permanent CEO, NYT says
- 01/10/23
- Franchise Group could go private or may bid to buy Conn's, WSJ reports
- $416.02 /
-34.745 (-7.71%) - 05/15/23
- IRS considers creating government-run tax-prep alternative, WSJ reports
- 01/18/23
- Intuit admits to MailChimp data breach, NY Post reports
- $212.74 /
+8.215 (+4.02%) - 05/24/23
- Illumina director says company strong enough to survive loss of CEO, FT reports
- 05/10/23
- Glass Lewis backs Icahn's effort to oust Illumina CEO, chair, FT reports
- 03/29/23
- Icahn seeks to bring back Illumina's former CEO, WSJ reports
- 03/13/23
- Icahn planning proxy fight at Illumina, WSJ reports
- 05/21/23
- Fintech should be scared as Apple reaches deeper into pockets, Barron's says
- 05/24/23
- Jana plans Freshpet proxy battle after amassing 9% stake, WSJ says
- 05/24/23
- Jana plans Freshpet proxy bottle after amassing 9% stake, WSJ says
- 05/24/23
- Jana has 9% stake in Freshpet, plans proxy battle, WSJ reports
- 05/03/23
- Freshpet management 'strongly prefer' to remain independent, Dealreporter says
- 05/19/23
- Yellen tells large bank CEOs more mergers may be needed, CNN reports
- 05/01/23
- Biden calls congressional leaders for debt ceiling talks on May 9, CNN reports
- 04/12/23
- U.S. banks that aided in First Republic rescue add to reserves, Bloomberg says
- 04/11/23
- Citi's global M&A co-head Mark Shafir to retire, WSJ reports
- 05/24/23
- Avid Technology working with Goldman on potential sale, Reuters reports
- 05/24/23
- Avid Technology working with Goldman on potential sale, Reuters reports
- 05/24/23
- Apple's iOS 17 to let locked iPhones appear as smart displays, Bloomberg says
- 05/24/23
- Apple's iOS 17 to let locked iPhones appear as smart displays, Bloomberg says
- 05/24/23
- Apple's iOS 17 to let locked iPhones appear as smart displays, Bloomberg says
- 05/24/23
- DoorDash sued in $1B lawsuit for charging iPhone users more, NY Post reports
- 03/29/23
- Powell did not 'predict' another rate hike in meeting, CNBC reports
- 03/08/23
- Biden to propose 25% billionaire tax, Bloomberg says
- 03/08/23
- Biden to propose 25% billionaire tax, Bloomberg says
- 03/07/23
- Powell tells Congress data from January partly reversed softening trends
- 05/08/23
- Here's what Wall Street experts are saying about these EV names ahead of results
- 05/01/23
- What You Missed This Week in EVs and Clean Energy
- 04/25/23
- What You Missed On Wall Street On Tuesday
- 04/03/23
- Fly Insider: Kohl's, 89Bio among week's notable insider trades
- 02/22/23
- What You Missed On Wall Street On Wednesday
- $131.37 /
-15.59 (-10.61%) - 05/18/23
- Biotech Alert: Searches spiking for these stocks today
- 02/08/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/24/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 05/09/23
- What You Missed On Wall Street On Tuesday
- $18.69 /
-5.045 (-21.26%) - 03/16/23
- What You Missed On Wall Street On Thursday
- 05/24/23
- Here's what Wall Street experts are saying about Nvidia ahead of earnings
- 05/21/23
- Opening Day: Monogram Orthopaedics stock soars in trading debut
- 05/24/23
- #SocialStocks: Meta fined EUR 1.2B in Ireland for infringing on data laws
- $416.02 /
-34.745 (-7.71%) - 05/24/23
- What You Missed On Wall Street On Wednesday
- 05/24/23
- What You Missed On Wall Street This Morning
- 05/24/23
- Fly Intel: Pre-market Movers
- 05/23/23
- Fly Intel: After-Hours Movers
- $212.74 /
+8.215 (+4.02%) - 05/10/23
- What You Missed On Wall Street On Wednesday
- 05/10/23
- What You Missed On Wall Street This Morning
IART Integra LifeSciences - 05/23/23
- What You Missed On Wall Street On Tuesday
- 05/08/23
- What You Missed On Wall Street On Monday
- 05/08/23
- What You Missed On Wall Street This Morning
- 02/21/23
- Fly Intel: After-Hours Movers
- 05/11/23
- What You Missed On Wall Street On Thursday
- 05/11/23
- What You Missed On Wall Street This Morning
- 03/01/23
- Fly Intel: After-Hours Movers
- $30.18 /
+7.105 (+30.80%) - 04/12/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- $173.26 /
-14.59 (-7.77%) - 02/27/23
- Fly Insider: Impinj, Airbnb among week's notable insider trades
- 04/28/23
- What You Missed On Wall Street On Friday
- 05/23/23
- What You Missed On Wall Street This Morning
- 05/22/23
- What You Missed On Wall Street On Monday
- 05/03/23
- What You Missed On Wall Street On Wednesday
- 04/19/23
- What You Missed On Wall Street On Wednesday
- 03/22/23
- What You Missed On Wall Street On Wednesday
- 05/23/23
- XPeng call volume above normal and directionally bullish
- 05/11/23
- XPeng call volume above normal and directionally bullish
- 05/02/23
- Largest borrow rate increases among liquid names
- 04/26/23
- XPeng call volume above normal and directionally bullish
- $31.34 /
+4.675 (+17.54%) - 05/23/23
- Urban Outfitters options imply 9.1% move in share price post-earnings
- 02/01/23
- Urban Outfitters put volume heavy and directionally bearish
- 01/05/23
- Urban Outfitters put volume heavy and directionally bearish
- 05/23/23
- Toll Brothers options imply 4.4% move in share price post-earnings
- 02/28/23
- Largest borrow rate increases among liquid names
- 02/21/23
- Toll Brothers options imply 4.7% move in share price post-earnings
- 12/06/22
- Toll Brothers options imply 4.4% move in share price post-earnings
- $131.37 /
-15.59 (-10.61%) - 05/11/23
- Unusually active option classes on open May 11th
- 04/11/23
- Sarepta put volume heavy and directionally bearish
- 03/27/23
- Sarepta call volume above normal and directionally bullish
- 03/24/23
- SPX options flow afternoon update
- 05/23/23
- Largest borrow rate increases among liquid names
- 05/09/23
- Unusually active option classes on open May 9th
- 05/05/23
- Notable open interest changes for May 5th
- 05/04/23
- Unusually active option classes on open May 4th
- $204.38 /
+14.465 (+7.62%) - 05/23/23
- Palo Alto Networks options imply 6.8% move in share price post-earnings
- 02/21/23
- Palo Alto Networks options imply 6.7% move in share price post-earnings
- 05/24/23
- NVIDIA put buyer realizes 20% same-day gains
- 05/19/23
- Notable open interest changes for May 19th
- 05/09/23
- Notable open interest changes for May 9th
- 05/08/23
- NVIDIA call buyer realizes 82% same-day gains
- 05/22/23
- Early notable gainers among liquid option names on May 22nd
- 04/28/23
- Notable open interest changes for April 28th
- 04/27/23
- Early notable gainers among liquid option names on April 27th
- 04/27/23
- Notable open interest changes for April 27th
- 05/15/23
- Kohl's call volume above normal and directionally bullish
- 05/12/23
- Kohl's call volume above normal and directionally bullish
- 04/25/23
- Kohl's put volume heavy and directionally bearish
- $416.02 /
-34.745 (-7.71%) - 05/23/23
- Intuit options imply 4.0% move in share price post-earnings
- 02/24/23
- Early notable gainers among liquid option names on February 24th
- 11/29/22
- Intuit options imply 5.6% move in share price post-earnings
- $212.74 /
+8.215 (+4.02%) - 05/24/23
- Illumina call volume above normal and directionally bullish
- 05/19/23
- Illumina call volume above normal and directionally bullish
- 05/18/23
- Illumina call volume above normal and directionally bullish
- 05/10/23
- Early notable gainers among liquid option names on May 10th
- 04/18/23
- Unusually active option classes on open April 18th
- 03/09/23
- World Low Volatility ETF put volume heavy and directionally bearish
- 01/17/23
- Unusually active option classes on open January 17th
- 05/02/23
- Camping World options imply 7.2% move in share price post-earnings
- 02/23/23
- Camping World put buyer realizes 232% same-day gains
- 02/21/23
- Camping World options imply 8.9% move in share price post-earnings
- 02/14/23
- Camping World put volume heavy and directionally bearish
- 05/24/23
- Unusually active option classes on open May 24th
- 04/14/23
- Early notable gainers among liquid option names on April 14th
- 04/14/23
- Unusually active option classes on open April 14th
- 03/24/23
- Citi put buyer realizes 50% same-day gains
- $173.26 /
-14.59 (-7.77%) - 02/15/23
- Early notable gainers among liquid option names on February 15th
- 01/05/23
- Analog Devices put volume heavy and directionally bearish
- 01/09/23
- Accolade options imply 10.9% move in share price post-earnings
- 05/24/23
- Notable open interest changes for May 24th
- 05/23/23
- Notable open interest changes for May 23rd
- 05/22/23
- Notable open interest changes for May 22nd
SPY SPDR S&P 500 ETF Trust - 05/24/23
- SPDR S&P 500 ETF Trust: Pivot points
- 05/23/23
- SPDR S&P 500 ETF Trust: Pivot points
- 05/22/23
- SPDR S&P 500 ETF Trust: Pivot points
- 05/19/23
- SPDR S&P 500 ETF Trust: Pivot points
- 03/22/23
- Fed says 'additional policy firming may be appropriate'
|
On The Fly
|
Get caught up quickly on… ShowHide Related Items >><< - 03/22/23
- Petco falls 7% to $9.44 after Q4 results, FY23 guidance
- 03/22/23
- Petco expects to make $100M in principal payments on term loan in FY23
- 03/22/23
- Petco sees FY23 CapEx $225M-$250M
- $31.08 /
+4.415 (+16.56%) - 03/06/23
- Urban Outfitters COO Conforti sells 42,000 common shares
- 02/28/23
- Urban Outfitters says Q1 revenue growth could be 'similar to Q4'
- 02/28/23
- Urban Outfitters reports comparable retail segment sales up 3%
- 01/09/23
- Urban Outfitters reports holiday sales increased 2.3%
- 05/23/23
- Toll Brothers sees FY23 deliveries 8,900-9,500
- 05/23/23
- Toll Brothers sees Q3 deliveries 2,350-2,450
- 04/27/23
- Pending home sales decreased 5.2% in March amid limited supply, NAR says
- 03/15/23
- Toll Brothers Apartment Living breaks ground on Vermeer
- $130.12 /
-16.84 (-11.46%) - 05/24/23
- Sarepta to remain in quiet period during FDA BLA review for SRP-9001
- 05/24/23
- Sarepta: FDA working towards accelerated approval for SRP-9001 for DMD treatment
- 05/15/23
- Sarepta jumps 26% to $150.96 following positive FDA panel vote
- 05/13/23
- Sarepta confirms FDA panel vote in favor of DMD gene therapy
- 04/30/23
- Fly Intel: Top five weekend stock stories
- 04/25/23
- Sherwin-Williams sees Q2 net sales up or down low-single digit %
- 04/19/23
- Sherwin-Williams to divest China paint business to Akzo Nobel N.V.
- 04/19/23
- Sherwin-Williams signs purchase agreement with Akzo Nobel N.V.
- 05/04/23
- Shopify rises 27.3%
- 05/04/23
- Shopify rises 22.3%
- 05/04/23
- Shopify rises 19.0%
- 05/04/23
- Shopify says 'will be smaller by about 20%' after today
- 03/22/23
- Shoe Carnival increases dividend 11% to 10c
- 03/16/23
- Shoe Carnival names Erik Gast CFO
- 12/15/22
- Shoe Carnival announces new $50M share repurchase program
- $45.59 /
-12.86 (-22.00%) - 05/23/23
- PTC Therapeutics down 21% after announced gene therapy program discontinuation
- 05/23/23
- PTC Therapeutics terminates employment of CFO Emily Hill
- 05/23/23
- PTC Therapeutics to reduce workforce by about 8%
- 05/23/23
- PTC's MOVE-FA trial of vatiquinone did not meet its primary endpoint
- $18.80 /
-4.935 (-20.79%) - 05/24/23
- Children's Place plans to close 80-100 stores in 2023
- 05/10/23
- Children's Place announces election of all director candidates
- 02/06/23
- Children's Place falls 10% to $42.08 after lowering Q4 outlook
- $205.24 /
+15.325 (+8.07%) - 05/23/23
- Palo Alto Networks expects supply chains to normalize exiting FY23
- 05/23/23
- Palo Alto Networks says deal scrutiny has increased
- 05/23/23
- Palo Alto Networks sees FY23 adjusted free cash flow margin 37.5%-38.5%
- 04/25/23
- Accenture, Palo Alto Networks collaborate to deliver SASE solutions
- 04/27/23
- Organogenesis President, CEO Gillheeney, Sr. elected as chair of the board
- 03/27/23
- Organogenesis applauds findings from the Office of Inspector General
- 03/20/23
- S&P announces changes to S&P 400, 600 indices at open on 3/20
NVTS Navitas Semiconductor - 05/22/23
- Navitas Semiconductor to be added to Russell 3000 Index
- 05/18/23
- Navitas Semiconductor's next-gen SiC power semis adopted industrial chargers
- 05/15/23
- Navitas Semiconductor sees FY23 revenue to double
- 04/25/23
- Navitas Semiconductor signs agreement with Mouser Electronics
- 05/23/23
- Nvidia integrating AI Enterprise software into Microsoft Azure Machine Learning
- 05/23/23
- Nvidia integrating AI Enterprise software into Microsoft Azure Machine Learning
- 05/23/23
- Dell Technologies, Nvidia to partner around on-premises generative AI
- 05/22/23
- Nvidia exec sells $7.04M in common stock
- 05/23/23
- Shutterstock to acquire GIPHY from Meta Platforms for $53M
- 05/23/23
- Shutterstock to acquire GIPHY from Meta Platforms for $53M
- 05/22/23
- Meta Platforms says Bombyx being licensed for product development
- 05/22/23
- WhatsApp introduces 'Edit' feature for sent messages
- 05/24/23
- Kohl's rises 10.6%
- 05/24/23
- Kohl's rises 14.7%
- 05/19/23
- Kohl's falls -9.6%
- 05/19/23
- Foot Locker names Mike Baughn as new CFO
- $416.75 /
-34.01 (-7.55%) - 05/23/23
- Intuit sees average revenue per return up 12%
- 05/15/23
- Tiger Global buys TSMC, exits AppLovin in Q1
- 05/04/23
- Intuit names CEOs of LinkedIn, Zoom Video to board
- 02/23/23
- Intuit names Sandeep Singh Aujla as new CFO
- 05/18/23
- Illumina board chair issues letter, urges shareholders to vote for all nominees
- 05/15/23
- Icahn bought Illumina in Q1, sold shares of Herc and Newell
- 05/15/23
- Icahn says Illumina shareholders 'clearly want more change'
- 05/15/23
- Illumina board urges shareholders to vote the WHITE proxy card
IART Integra LifeSciences - 05/23/23
- Integra LifeSciences falls 15% after product recall, Q2 guidance cut
- 05/23/23
- Integra LifeSciences voluntary recalls all products made in Boston plant
- 01/25/23
- Integra LifeSciences confirms Carrie Anderson to step down as CFO
- 01/25/23
- Campbell Soup names Carrie Anderson as new CFO
- 05/24/23
- Jana to nominate four to Freshpet board, citing 'pattern of missteps'
- 05/17/23
- Freshpet appoints Walter George as new independent chair
- 05/15/23
- Jana exited Encompass Health during Q1, bought more FIS
- 03/22/23
- Freshpet, Petco announce delivery partnership
- 05/08/23
- Camping World intends to acquire I-90 RV, as entry ino Montana RV market
- 05/03/23
- Camping World rises 11.8%
- 04/17/23
- Camping World increases California location count with All Seasons RV Yuba City
- 04/13/23
- Camping World to acquire All Seasons RV in Bend, Oregon
- 05/24/23
- CMA provisionally finds five banks broke competition law on U.K. bonds
- 05/24/23
- Citi to resume 'modest' level of share buybacks this quarter
- 05/24/23
- Citi to pursue IPO of Banco Nacional de Mexico business
- 05/24/23
- Citi to pursue IPO of Mexico business Banamex
- 05/24/23
- Abercrombie & Fitch rises 26.0%
- 05/24/23
- Abercrombie & Fitch rises 20.7%
- 05/24/23
- Abercrombie & Fitch rises 18.1%
- 03/30/23
- Abercrombie & Fitch launches co-designed collection with Tia Booth
- $172.13 /
-15.715 (-8.37%) - 05/24/23
- Microchip reiterates prior guidance on backlog confidence
- 05/24/23
- Analog falls 6% after Q3 EPS view and expectations of moderating revenue
- 05/24/23
- Analog Devices: Longer term focus for data processing shifting 'to the edge'
- 05/24/23
- Analog Devices sees 2H revenue to moderate amid 'continued economic uncertainty'
- 02/16/23
- Accolade announces Michael Hilton to join board of directors
- 02/06/23
- Cathie Wood's ARK Investment bought 313.7K shares of Accolade today
- $117.96 /
-10.75 (-8.35%) - 05/24/23
- Agilent falls -10.1%
- 05/24/23
- Agilent falls -10.0%
- 05/19/23
- Agilent intends to appeal PTAB decision regarding CRISPR guide RNA
- 03/14/23
- Axion BioSystems 'vigorously refutes' Agilent allegations
- $416.75 /
-34.01 (-7.55%) - 05/24/23 Piper Sandler
- Intuit price target lowered to $497 from $510 at Piper Sandler
- 05/24/23 BMO Capital
- Intuit price target raised to $485 from $462 at BMO Capital
- 05/24/23 BofA
- Intuit price target raised to $500 from $485 at BofA
- 05/24/23 Morgan Stanley
- Intuit price target raised to $525 from $520 at Morgan Stanley
- 05/12/23 Evercore ISI
- Citi price target lowered to $50 from $53 at Evercore ISI
- 04/17/23 BMO Capital
- Citi price target raised to $68 from $56 at BMO Capital
- 04/17/23 BofA
- Citi price target raised to $58 from $56 at BofA
- 04/17/23 RBC Capital
- Large banks' earnings 'much better than expected', says RBC Capital
- $205.24 /
+15.325 (+8.07%) - 05/24/23 Deutsche Bank
- Palo Alto Networks price target raised to $225 from $210 at Deutsche Bank
- 05/24/23 Loop Capital
- Palo Alto Networks price target raised to $240 from $225 at Loop Capital
- 05/24/23 Baird
- Palo Alto Networks price target raised to $235 from $230 at Baird
- 05/24/23 Evercore ISI
- Palo Alto Networks price target raised to $240 from $215 at Evercore ISI
- 05/16/23 Citi
- Kohl's price target lowered to $19 from $26 at Citi
- 03/29/23 UBS
- Kohl's price target lowered to $16 from $18 at UBS
- 03/02/23 Deutsche Bank
- Kohl's price target lowered to $31 from $34 at Deutsche Bank
- 03/02/23 Citi
- Kohl's price target lowered to $26 from $29 at Citi
- $130.12 /
-16.84 (-11.46%) - 05/24/23 Citi
- Sarepta may trade 'towards $120s,' should be bought on weakness, says Citi
- 05/16/23 RBC Capital
- Sarepta price target raised to $218 from $197 at RBC Capital
- 05/15/23 BofA
- Sarepta price target raised to $176 from $164 at BofA
- 05/15/23 UBS
- Sarepta price target raised to $173 from $160 at UBS
- 05/24/23 Exane BNP Paribas
- Exane downgrades Shopify to Underperform on small business exposure
- 05/24/23 Exane BNP Paribas
- Shopify downgraded to Underperform from Neutral at Exane BNP Paribas
- 05/23/23 BofA
- Global-e Online price target raised to $42 from $36 at BofA
- 05/09/23 Loop Capital
- Shopify price target raised to $69 from $60 at Loop Capital
- 05/24/23 BMO Capital
- Camping World upgraded to Outperform from Market Perform at BMO Capital
- 05/04/23 Raymond James
- Camping World price target lowered to $27 from $28 at Raymond James
- 04/18/23 KeyBanc
- Camping World coverage transitioned with an Overweight at KeyBanc
- 02/23/23 BMO Capital
- Camping World price target lowered to $26 from $30 at BMO Capital
- 05/24/23 BofA
- BofA upgrades Accolade to Buy on 'highly appealing' risk/reward
- 05/24/23 BofA
- Accolade upgraded to Buy from Neutral at BofA
- 05/09/23 Wells Fargo
- Wells says high-teen revenue CAGR 'likely more realistic' for Accolade
- 05/02/23 Piper Sandler
- Accolade should be bought into investor day, says Piper Sandler
- 05/24/23 Jefferies
- Sherwin-Williams upgraded to Buy from Hold at Jefferies
- 04/27/23 Deutsche Bank
- Sherwin-Williams price target raised to $265 from $260 at Deutsche Bank
- 04/27/23 Barclays
- Sherwin-Williams price target raised to $240 from $220 at Barclays
- 04/26/23 BMO Capital
- Sherwin-Williams price target raised to $253 from $231 at BMO Capital
IART Integra LifeSciences - 05/24/23 JPMorgan
- Integra LifeSciences downgraded to Underweight from Neutral at JPMorgan
- 05/23/23 BTIG
- Organogenesis upgraded to Buy from Neutral at BTIG
- 05/23/23 Citi
- Citi downgrades Integra to Sell, sees further guidance cuts
- 05/23/23 Citi
- Integra LifeSciences downgraded to Sell from Neutral at Citi
- 05/23/23 Piper Sandler
- Meta's AI initiatives could drive revenue recapture, says Piper Sandler
- 05/23/23 Citi
- Citi sees minimal risk to Meta Platforms after E.U. data fine
- 05/22/23 Evercore ISI
- Meta, Spotify, Zillow removed from 'Tactical Outperform' list at Evercore ISI
- 05/19/23 Roth MKM
- Meta Platforms' capex may decline in 2023-2024, says Roth MKM
- 05/24/23 Citi
- Citi ups Nvidia target to $363 on mobile AI market opportunity
- 05/23/23 Stifel
- Nvidia price target raised to $300 from $225 at Stifel
- 05/23/23 BofA
- AMD price target raised to $120 from $105 at BofA
- 05/22/23 Wedbush
- Nvidia price target raised to $290 from $216 at Wedbush
- 04/26/23 Stifel
- Illumina price target raised to $265 from $235 at Stifel
- 04/26/23 Baird
- Illumina price target raised to $229 from $224 at Baird
- 03/13/23 Piper Sandler
- Piper agrees with Icahn, says Illumina base business undervalued
- 02/14/23 UBS
- Illumina price target lowered to $240 from $255 at UBS
- 04/09/23 Goldman Sachs
- Tata Motors upgraded to Buy from Neutral at Goldman Sachs
- 01/31/23 Citi
- Tata Motors resumed with a Buy at Citi
- 01/09/23 BofA
- Tata Motors upgraded to Buy from Neutral at BofA
- 10/10/22 JPMorgan
- Tata Motors downgraded to Neutral from Overweight at JPMorgan
- 05/09/23 Baird
- Freshpet price target raised to $80 from $75 at Baird
- 02/28/23 Truist
- Freshpet price target raised to $55 from $40 at Truist
- 02/28/23 Baird
- Freshpet price target raised to $75 from $70 at Baird
- 02/28/23 Credit Suisse
- Freshpet price target raised to $65 from $60 at Credit Suisse
- 03/12/23 BTIG
- BTIG finds medical technology stocks with exposure with SVB
- 11/10/22 BTIG
- Organogenesis downgraded to Neutral from Buy at BTIG
- 08/10/22 Oppenheimer
- Oppenheimer downgrades Organogenesis to Perform on lowered guidance
- $31.08 /
+4.415 (+16.56%) - 05/24/23 Deutsche Bank
- Urban Outfitters price target raised to $29 from $26 at Deutsche Bank
- 05/24/23 BMO Capital
- Urban Outfitters price target raised to $31 from $25 at BMO Capital
- 05/24/23 Baird
- Urban Outfitters price target raised to $32 from $30 at Baird
- $45.59 /
-12.86 (-22.00%) - 05/24/23 TD Cowen
- PTC Therapeutics price target lowered to $40 from $47 at TD Cowen
- 05/24/23 Credit Suisse
- PTC Therapeutics price target lowered to $50 from $55 at Credit Suisse
- 05/24/23 Citi
- PTC Therapeutics price target lowered to $63 from $70 at Citi
- 05/24/23 Barclays
- PTC Therapeutics price target lowered to $48 from $57 at Barclays
- $18.80 /
-4.935 (-20.79%) - 05/11/23 B. Riley
- Children's Place initiated with a Buy at B. Riley
- 03/29/23 UBS
- Children's Place price target lowered to $40 from $45 at UBS
- 02/07/23 Telsey Advisory
- Children's Place downgraded to Market Perform from Outperform at Telsey
- 11/18/22 UBS
- Children's Place price target lowered to $41 from $43 at UBS
- 04/28/23 Gordon Haskett
- Petco initiated with a Hold, $10 target at Gordon Haskett
- 04/28/23 Gordon Haskett
- Petco initiated with a Hold at Gordon Haskett
- 04/14/23 Needham
- Petco price target lowered to $15 from $20 at Needham
- 03/29/23 BofA
- Petco price target lowered to $14.50 from $18 at BofA
NVTS Navitas Semiconductor - 05/16/23 Deutsche Bank
- Navitas Semiconductor price target raised to $9 from $8 at Deutsche Bank
- 05/16/23 BofA
- Navitas Semiconductor price target raised to $8 from $7 at BofA
- 02/24/23 Deutsche Bank
- Navitas Semiconductor price target raised to $8 from $6 at Deutsche Bank
- 02/24/23 Baird
- Navitas Semiconductor price target raised to $10 from $8 at Baird
- 05/24/23 Credit Suisse
- Toll Brothers price target raised to $73 from $63 at Credit Suisse
- 02/23/23 BofA
- Toll Brothers price target raised to $70 from $68 at BofA
- 02/23/23 Raymond James
- Toll Brothers price target raised to $67 from $61 at Raymond James
- 01/18/23 Oppenheimer
- Toll Brothers initiated with an Outperform at Oppenheimer
- $117.96 /
-10.75 (-8.35%) - 05/24/23 SVB Securities
- Agilent price target lowered to $145 from $170 at SVB Securities
- 05/24/23 Evercore ISI
- Agilent price target lowered to $126 from $150 at Evercore ISI
- 05/24/23 TD Cowen
- Agilent price target lowered to $145 from $168 at TD Cowen
- 05/24/23 BofA
- Agilent price target lowered to $144 from $164 at BofA
- $172.13 /
-15.715 (-8.37%) - 03/28/23 Wells Fargo
- Wells Fargo sees Infineon's increased expectations as positive for NXP, others
- 02/16/23 Deutsche Bank
- Analog Devices price target raised to $200 from $170 at Deutsche Bank
- 02/16/23 Stifel
- Analog Devices price target raised to $225 from $195 at Stifel
- 02/16/23 BMO Capital
- Analog Devices price target raised to $215 from $195 at BMO Capital
- 05/18/23 Citi
- Abercrombie & Fitch price target lowered to $24 from $32 at Citi
- 05/09/23 Jefferies
- Abercrombie & Fitch price target lowered to $30 from $35 at Jefferies
- 04/12/23 Argus
- Abercrombie & Fitch cut to Hold at Argus amid margin pressure, consumer caution
- 04/12/23 Argus
- Abercrombie & Fitch downgraded to Hold from Buy at Argus
- 05/01/23 Williams Trading
- Shoe Carnival downgraded to Hold from Buy at Williams Trading
- 05/24/23
- Petco backs FY23 adjusted EPS view 40c-48c, consensus 45c
- 05/24/23
- Petco reports Q1 adjusted EPS 6c, consensus 5c
- $31.08 /
+4.415 (+16.56%) - 05/23/23
- Urban Outfitters reports Q1 EPS 56c, consensus 35c
- 02/28/23
- Urban Outfitters reports Q4 EPS 34c, consensus 38c
- 05/23/23
- Toll Brothers reports Q2 EPS $2.85, consensus $1.91
- 02/21/23
- Toll Brothers affirms FY23 EPS view of $8.00-$9.00, consensus $8.41
- 02/21/23
- Toll Brothers reports Q1 EPS $1.70, consensus $1.41
- $130.12 /
-16.84 (-11.46%) - 05/02/23
- Sarepta Therapeutics reports Q1 adjusted EPS (97c), consensus ($1.38)
- 02/28/23
- Sarepta reports Q4 EPS ($1.24), consensus ($1.35)
- 01/09/23
- Sarepta expects to exceed FY22 guidance for net product revenues
- 04/25/23
- Sherwin-Williams sees FY23 adjusted EPS $7.95-$8.65, consensus $8.48
- 04/25/23
- Sherwin-Williams reports Q1 adjusted EPS $2.04, consensus $1.78
- 04/24/23
- Notable companies reporting before tomorrow's open
- 05/04/23
- Shopify sees Q2 revenue growth rate similar to Q1
- 05/04/23
- Shopify reports Q1 adjusted EPS 1c, consensus (4c)
- 02/15/23
- Shopify sees Q1 revenue growth in high teens percentages
- 02/15/23
- Shopify reports Q4 adjusted EPS 7c, consensus (1c)
- 05/24/23
- Shoe Carnival lowers FY23 EPS view to $3.60-$3.85 from $3.96-$4.20
- 05/24/23
- Shoe Carnival reports Q1 EPS 60c, consensus 69c
- 03/22/23
- Shoe Carnival sees Q1 mid-single digit decline in net sales, consensus $331.2M
- 03/22/23
- Shoe Carnival sees FY23 EPS $3.96-$4.20, consensus $4.29
- $45.59 /
-12.86 (-22.00%) - 04/27/23
- PTC Therapeutics backs 2023 revenue view $940M-$1.0B, consensus $866.89M
- 04/27/23
- PTC Therapeutics reports Q1 EPS ($1.88), consensus ($1.39)
- 02/21/23
- PTC Therapeutics backs FY23 revenue view $940M-$1B, consensus $898.56M
- 02/21/23
- PTC Therapeutics reports Q4 EPS ($2.35), consensus ($1.59)
- $18.80 /
-4.935 (-20.79%) - 05/24/23
- Children's Place sees 2023 adjusted EPS $1.00-$1.50, consensus $2.15
- 05/24/23
- Children's Place sees Q2 adjusted EPS ($2.15)-($2.20), consensus ($1.56)
- 05/24/23
- Children's Place reports Q1 adjusted EPS ($2.00), consensus ($1.83)
- 03/16/23
- Children's Place sees FY23 adjusted EPS $2.50-$3.00, consensus $3.35
- $205.24 /
+15.325 (+8.07%) - 05/23/23
- Palo Alto Networks raises FY23 adjusted EPS view to $4.25-$4.29 from $3.97-$4.03
- 05/23/23
- Palo Alto Networks sees Q4 adjusted EPS $1.26-$1.30, consensus $1.20
- 05/23/23
- Palo Alto Networks reports Q3 adjusted EPS $1.10, consensus 93c
- 05/10/23
- Organogenesis reports Q1 EPS (2c), consensus (2c)
NVTS Navitas Semiconductor - 05/15/23
- Navitas Semiconductor sees Q2 revenue $16M-$17M, consensus $15.17M
- 05/15/23
- Navitas Semiconductor reports Q1 EPS (7c), consensus (8c)
- 02/23/23
- Navitas Semiconductor sees Q1 revenue flat, consensus $13.05M
- 02/23/23
- Navitas Semiconductor reports Q4 EPS (6c), consensus (8c)
- 02/22/23
- Nvidia sees Q1 revenue $6.5B plus of minus 2%, consensus $6.33B
- 02/22/23
- Nvidia reports Q4 EPS 88c, consensus 81c
- 02/22/23
- Notable companies reporting after market close
- 05/21/23
- Fly Intel: Top five weekend stock stories
- 04/26/23
- Meta Platforms sees Q2 revenue $29.5B-$32B, consensus $29.48B
- 04/26/23
- Meta Platforms reports Q1 EPS $2.20, consensus $2.53
- 04/26/23
- Notable companies reporting after market close
- 05/24/23
- Kohl's backs FY23 EPS $2.10-$2.70 view, consensus $2.32
- 05/24/23
- Kohl's reports Q1 EPS 13c, consensus (42c)
- 05/23/23
- Notable companies reporting before tomorrow's open
- $416.75 /
-34.01 (-7.55%) - 05/23/23
- Intuit sees Q4 EPS $1.43-$1.48, consensus $1.51
- 05/23/23
- Intuit sees FY23 EPS $14.20-$14.25, consensus $13.83
- 05/23/23
- Intuit reports Q3 EPS $8.92, consensus $8.48
- 05/23/23
- Notable companies reporting after market close
- 04/25/23
- Illumina reports Q1 non-GAAP EPS 8c, consensus 2c
- 04/25/23
- Illumina sees FY23 non GAAP EPS $1.25-$1.50, consensus $1.41
- 04/25/23
- Illumina reports Q1 EPS 2c, consensus 2c
- 04/25/23
- Notable companies reporting after market close
IART Integra LifeSciences - 05/23/23
- Integra LifeSciences sees Q2 adjusted EPS 55c-59c, consensus 77c
- 04/26/23
- Integra LifeSciences sees Q2 adjusted EPS 75c-79c, consensus 85c
- 04/26/23
- Integra LifeSciences backs FY23 adjusted EPS view $3.43-$3.51, consensus $3.48
- 04/26/23
- Integra LifeSciences reports Q1 adjusted EPS 74c, consensus 74c
- 05/08/23
- Freshpet sees 2023 revenue $750M, consensus $752.3M
- 05/08/23
- Freshpet reports Q1 EPS (52c), consensus (44c)
- 02/27/23
- Freshpet sees 2023 net sales about $750M, consensus $755.01M
- 02/27/23
- Freshpet reports Q4 EPS (6c), consensus (9c)
- 05/02/23
- Camping World reports Q1 EPS 5c, consensus (6c)
- 02/21/23
- Camping World reports Q4 EPS (20c), consensus 1c
- 04/14/23
- Citi reports Q1 EPS $2.19, consensus $1.67
- 04/13/23
- Notable companies reporting before tomorrow's open
- 01/13/23
- Citi sees Q1 revenues up mid-single digits, consensus $19.37B
- 01/13/23
- Citi sees FY23 revenue $78B-$79B, consensus $76.15B
- 05/24/23
- Abercrombie & Fitch sees Q2 revenue up 4%-6% vs. 2Q22, consensus $813.27M
- 05/24/23
- Abercrombie & Fitch raises 2023 revenue growth view 2%-4% from 1%-3%
- 05/24/23
- Abercrombie & Fitch reports Q1 adjusted EPS 39c, consensus (5c)
- 03/01/23
- Abercrombie & Fitch sees Q1 revenue flat vs. 1Q22, consensus $795.74M
- $172.13 /
-15.715 (-8.37%) - 05/24/23
- Analog Devices sees Q3 EPS $2.42-$2.62 , consensus $2.65
- 05/24/23
- Analog Devices reports Q2 EPS $2.83, consensus $2.75
- 04/27/23
- Accolade sees FY24 revenue $410M, consensus $409.94M
- 04/27/23
- Accolade sees Q1 revenue $89M-$91M, consensus $94.51M
- 04/27/23
- Accolade reports Q4 EPS (42c), consensus (42c)
- 01/09/23
- Accolade guides initial FY24 revenue around $410M, consensus $405.4M
- $117.96 /
-10.75 (-8.35%) - 05/23/23
- Agilent sees FY23 EPS $5.60-$5.56, consensus $5.69
- 05/23/23
- Agilent sees Q3 EPS $1.36-$1.38, consensus $1.43
- 05/23/23
- Agilent reports Q2 EPS $1.27, consensus $1.26
- 02/28/23
- Agilent sees FY23 EPS $5.65-$5.70, consensus $5.66
|
On The Fly
|
The most talked about and… ShowHide Related Items >><< - 05/15/23
- Tiger Global buys TSMC, exits AppLovin in Q1
- 03/06/23
- Urban Outfitters COO Conforti sells 42,000 common shares
- 02/28/23
- Urban Outfitters says Q1 revenue growth could be 'similar to Q4'
- 02/28/23
- Urban Outfitters reports comparable retail segment sales up 3%
- 01/09/23
- Urban Outfitters reports holiday sales increased 2.3%
- 05/15/23
- Greenlight Capital exits positions in Victoria's Secret, Funko
- 04/27/23
- Southwestern Energy sees Q2 total production 408-420 Bcfe
- 02/14/23
- Greenlight buys Tenet, exits Intel in Q4
- 12/04/22
- Fly Intel: Top five weekend stock stories
- 04/30/23
- Fly Intel: Top five weekend stock stories
- 04/25/23
- Sherwin-Williams sees Q2 net sales up or down low-single digit %
- 04/19/23
- Sherwin-Williams to divest China paint business to Akzo Nobel N.V.
- 04/19/23
- Sherwin-Williams signs purchase agreement with Akzo Nobel N.V.
- 05/04/23
- Shopify rises 27.3%
- 05/04/23
- Shopify rises 22.3%
- 05/04/23
- Shopify rises 19.0%
- 05/04/23
- Shopify says 'will be smaller by about 20%' after today
- 02/07/23
- RXO Inc. confident in achieving 5-year financial targets
- 01/04/23
- RXO to replace The Joint in the S&P SmallCap 600 at open on January 5
- 12/29/22
- RXO Inc. rises 5.4%
- 12/28/22
- RXO Inc up 4% at $16.90 after entering S&P SmallCap 600 index
- 05/24/23
- PTC director sells $5.38M in common stock
- 05/22/23
- PTC director sells $10.73M in common stock
- 05/11/23
- PTC director sells $5.22M in common stock
- 04/19/23
- PTC director sells $2.72M in common stock
- 12/05/22
- Owens Corning completes sale of Russian operations, affirms Q4 guidance
- 12/02/22
- Owens Corning announces dividend increase, new share repurchase authorization
- 05/22/23
- Ideaya Biosciences announces FDA clearance of IDE397 study
- 04/23/23
- Ideaya announces interim Phase 2 data for darovasertib, crizotinib combination
- 04/19/23
- Ideaya Biosciences announces first patient dosed in IDE161 trial
- 01/23/23
- Ideaya Biosciences provides update on darovasertib trials
IART Integra LifeSciences - 05/23/23
- Integra LifeSciences falls 15% after product recall, Q2 guidance cut
- 05/23/23
- Integra LifeSciences voluntary recalls all products made in Boston plant
- 01/25/23
- Integra LifeSciences confirms Carrie Anderson to step down as CFO
- 01/25/23
- Campbell Soup names Carrie Anderson as new CFO
- 05/08/23
- Camping World intends to acquire I-90 RV, as entry ino Montana RV market
- 05/03/23
- Camping World rises 11.8%
- 04/17/23
- Camping World increases California location count with All Seasons RV Yuba City
- 04/13/23
- Camping World to acquire All Seasons RV in Bend, Oregon
- 05/15/23
- Canadian Solar subsidiary signs aggregation deal for 100MW in Texas
- 03/27/23
- Autodesk names Sebastian Goodwin chief trust officer
- 02/21/23
- Procore announces Sarah Hodges as CMO, effective immediately
- 02/14/23
- Lone Pine exited PayPal, initiated AMD position during Q4
- 02/16/23
- Accolade announces Michael Hilton to join board of directors
- 02/06/23
- Cathie Wood's ARK Investment bought 313.7K shares of Accolade today
- $115.20 /
-13.51 (-10.50%) - 05/24/23
- Agilent falls -10.1%
- 05/24/23
- Agilent falls -10.0%
- 05/19/23
- Agilent intends to appeal PTAB decision regarding CRISPR guide RNA
- 03/14/23
- Axion BioSystems 'vigorously refutes' Agilent allegations
- 05/24/23 Deutsche Bank
- Urban Outfitters price target raised to $29 from $26 at Deutsche Bank
- 05/24/23 BMO Capital
- Urban Outfitters price target raised to $31 from $25 at BMO Capital
- 05/24/23 Baird
- Urban Outfitters price target raised to $32 from $30 at Baird
- 05/24/23 Jefferies
- Sherwin-Williams upgraded to Buy from Hold at Jefferies
- 04/27/23 Deutsche Bank
- Sherwin-Williams price target raised to $265 from $260 at Deutsche Bank
- 04/27/23 Barclays
- Sherwin-Williams price target raised to $240 from $220 at Barclays
- 04/26/23 BMO Capital
- Sherwin-Williams price target raised to $253 from $231 at BMO Capital
- 05/24/23 Barclays
- Owens Corning upgraded to Overweight from Equal Weight at Barclays
- 05/01/23 Deutsche Bank
- Owens Corning price target raised to $110 from $102 at Deutsche Bank
- 04/27/23 RBC Capital
- Owens Corning price target raised to $111 from $96 at RBC Capital
- 04/27/23 Barclays
- Owens Corning price target raised to $113 from $107 at Barclays
- 05/24/23 BMO Capital
- Camping World upgraded to Outperform from Market Perform at BMO Capital
- 05/04/23 Raymond James
- Camping World price target lowered to $27 from $28 at Raymond James
- 04/18/23 KeyBanc
- Camping World coverage transitioned with an Overweight at KeyBanc
- 02/23/23 BMO Capital
- Camping World price target lowered to $26 from $30 at BMO Capital
- 05/24/23 BofA
- BofA upgrades Accolade to Buy on 'highly appealing' risk/reward
- 05/24/23 BofA
- Accolade upgraded to Buy from Neutral at BofA
- 05/09/23 Wells Fargo
- Wells says high-teen revenue CAGR 'likely more realistic' for Accolade
- 05/02/23 Piper Sandler
- Accolade should be bought into investor day, says Piper Sandler
- 05/24/23 Exane BNP Paribas
- Exane downgrades Shopify to Underperform on small business exposure
- 05/24/23 Exane BNP Paribas
- Shopify downgraded to Underperform from Neutral at Exane BNP Paribas
- 05/23/23 BofA
- Global-e Online price target raised to $42 from $36 at BofA
- 05/09/23 Loop Capital
- Shopify price target raised to $69 from $60 at Loop Capital
- 05/24/23 Barclays
- SiteOne Landscape downgraded to Underweight from Equal Weight at Barclays
- 05/08/23 Stifel
- SiteOne Landscape price target raised to $140 from $125 at Stifel
- 05/08/23 Stifel
- Leslie's price target lowered to $11 from $12 at Stifel
- 05/05/23 Deutsche Bank
- SiteOne Landscape price target lowered to $153 from $163 at Deutsche Bank
- $115.20 /
-13.51 (-10.50%) - 05/24/23 SVB Securities
- Agilent price target lowered to $145 from $170 at SVB Securities
- 05/24/23 Evercore ISI
- Agilent price target lowered to $126 from $150 at Evercore ISI
- 05/24/23 TD Cowen
- Agilent price target lowered to $145 from $168 at TD Cowen
- 05/24/23 BofA
- Agilent price target lowered to $144 from $164 at BofA
- 05/24/23 Goldman Sachs
- Southwestern Energy downgraded to Sell from Neutral at Goldman Sachs
- 04/21/23 Susquehanna
- Southwestern Energy price target lowered to $7 from $7.50 at Susquehanna
- 04/19/23 Piper Sandler
- Southwestern Energy price target lowered to $8 from $9 at Piper Sandler
- 04/19/23 UBS
- Southwestern Energy initiated with a Neutral at UBS
IART Integra LifeSciences - 05/24/23 JPMorgan
- Integra LifeSciences downgraded to Underweight from Neutral at JPMorgan
- 05/23/23 BTIG
- Organogenesis upgraded to Buy from Neutral at BTIG
- 05/23/23 Citi
- Citi downgrades Integra to Sell, sees further guidance cuts
- 05/23/23 Citi
- Integra LifeSciences downgraded to Sell from Neutral at Citi
- 05/24/23 BMO Capital
- Autodesk initiated with a Market Perform at BMO Capital
- 05/23/23 Citi
- Autodesk price target lowered to $241 from $265 at Citi
- 05/19/23 Baird
- Autodesk price target lowered to $230 from $247 at Baird
- 05/19/23 Stifel
- Autodesk price target lowered to $240 from $245 at Stifel
- 05/24/23 BMO Capital
- PTC initiated with an Outperform at BMO Capital
- 05/17/23 Mizuho
- PTC price target raised to $170 from $165 at Mizuho
- 04/27/23 Barclays
- PTC price target raised to $152 from $150 at Barclays
- 04/24/23 Citi
- PTC price target lowered to $140 from $147 at Citi
- 05/24/23 JMP Securities
- Warby Parker initiated with a Market Perform at JMP Securities
- 05/10/23 Baird
- Warby Parker price target lowered to $18 from $20 at Baird
- 03/01/23 Morgan Stanley
- Warby Parker assumed with an Equal Weight at Morgan Stanley
- 03/01/23 TD Cowen
- Warby Parker price target lowered to $17 from $23 at Cowen
- 05/24/23 Barclays
- RXO Inc. initiated with an Overweight at Barclays
- 04/04/23 Benchmark
- RXO Inc. initiated with a Hold at Benchmark
- 02/27/23 TD Cowen
- RXO Inc. initiated with a Market Perform at Cowen
- 01/11/23 Stifel
- RXO Inc. downgraded to Hold from Buy at Stifel
- 05/24/23 Goldman Sachs
- Ideaya Biosciences initiated with a Buy at Goldman Sachs
- 04/24/23 Wedbush
- Ideaya Biosciences price target raised to $35 from $30 at Wedbush
- 04/24/23 Oppenheimer
- Ideaya Biosciences price target raised to $30 from $26 at Oppenheimer
- 04/24/23 Guggenheim
- Ideaya Biosciences price target raised to $40 from $32 at Guggenheim
- 05/09/23
- Warby Parker still sees 2023 revenue $645M-$660M, consensus $656.32M
- 05/09/23
- Warby Parker reports Q1 adjusted EPS 6c, consensus 5c
- 02/28/23
- Warby Parker sees 2023 revenue $645M-$660M, consensus $666.7M
- 02/28/23
- Warby Parker reports Q4 EPS (18c), consensus 0c
- 05/23/23
- Urban Outfitters reports Q1 EPS 56c, consensus 35c
- 02/28/23
- Urban Outfitters reports Q4 EPS 34c, consensus 38c
- 04/27/23
- Southwestern Energy reports Q1 adjusted EPS 31c, consensus 25c
- 02/23/23
- Southwestern Energy reports Q4 adjusted EPS 26c, consensus 27c
- 05/03/23
- SiteOne Landscape reaffirms FY23 adjusted EBITDA view $395M-$425M
- 05/03/23
- SiteOne Landscape reports Q1 EPS (10c), consensus 12c
- 02/15/23
- SiteOne Landscape sees FY23 adjusted EBITDA $395M-$425M
- 02/15/23
- SiteOne Landscape reports Q4 EPS (2c), consensus 13c
- 04/25/23
- Sherwin-Williams sees FY23 adjusted EPS $7.95-$8.65, consensus $8.48
- 04/25/23
- Sherwin-Williams reports Q1 adjusted EPS $2.04, consensus $1.78
- 04/24/23
- Notable companies reporting before tomorrow's open
- 05/04/23
- Shopify sees Q2 revenue growth rate similar to Q1
- 05/04/23
- Shopify reports Q1 adjusted EPS 1c, consensus (4c)
- 02/15/23
- Shopify sees Q1 revenue growth in high teens percentages
- 02/15/23
- Shopify reports Q4 adjusted EPS 7c, consensus (1c)
- 05/03/23
- RXO Inc. reports Q1 adjusted EPS 11c, consensus 7c
- 02/07/23
- RXO Inc. reports Q4 adjusted EPS 28c, consensus 30c
- 04/26/23
- PTC narrows FY23 revenue view to $2.08B-$2.14B from $2.07B-$2.15B
- 04/26/23
- PTC reports Q2 non-GAAP EPS $1.16,consensus $1.14
- 02/01/23
- PTC raises FY23 revenue view to $2.070B-$2.150B from $2.050B-$2.130B
- 02/01/23
- PTC reports Q1 adjusted EPS 99c, consensus $1.03
- 04/26/23
- Owens Corning sees 'moderate decline in net sales' in Q2, consensus $2.43B
- 04/26/23
- Owens Corning reports Q1 adjusted EPS $2.77, consensus $2.22
- 02/15/23
- Owens Corning sees 'moderate decline of net sales' in Q1, consensus $2.29B
- 02/15/23
- Owens Corning reports Q4 adjusted EPS $2.49, consensus $2.36
- 05/09/23
- Ideaya Biosciences reports Q1 EPS (49c), consensus (55c)
- 03/07/23
- Ideaya Biosciences reports Q4 EPS (50c), consensus (56c)
IART Integra LifeSciences - 05/23/23
- Integra LifeSciences sees Q2 adjusted EPS 55c-59c, consensus 77c
- 04/26/23
- Integra LifeSciences sees Q2 adjusted EPS 75c-79c, consensus 85c
- 04/26/23
- Integra LifeSciences backs FY23 adjusted EPS view $3.43-$3.51, consensus $3.48
- 04/26/23
- Integra LifeSciences reports Q1 adjusted EPS 74c, consensus 74c
- 05/02/23
- Camping World reports Q1 EPS 5c, consensus (6c)
- 02/21/23
- Camping World reports Q4 EPS (20c), consensus 1c
- 02/23/23
- Autodesk sees FY24 non-GAAP EPS $6.98-$7.32, consensus $7.31
- 02/23/23
- Autodesk reports 4Q non-GAAP EPS $1.86, consensus $1.81
- 02/23/23
- Notable companies reporting after market close
- 04/27/23
- Accolade sees FY24 revenue $410M, consensus $409.94M
- 04/27/23
- Accolade sees Q1 revenue $89M-$91M, consensus $94.51M
- 04/27/23
- Accolade reports Q4 EPS (42c), consensus (42c)
- 01/09/23
- Accolade guides initial FY24 revenue around $410M, consensus $405.4M
- $115.20 /
-13.51 (-10.50%) - 05/23/23
- Agilent sees FY23 EPS $5.60-$5.56, consensus $5.69
- 05/23/23
- Agilent sees Q3 EPS $1.36-$1.38, consensus $1.43
- 05/23/23
- Agilent reports Q2 EPS $1.27, consensus $1.26
- 02/28/23
- Agilent sees FY23 EPS $5.65-$5.70, consensus $5.66
|
Upgrade
|
Jefferies analyst… Jefferies analyst Laurence Alexander upgraded Sherwin-Williams to Buy from Hold with a price target of $275, up from $240. The analyst says the stock's risk/reward is improving as the housing market "troughs." The company's sales benefits from share gains, margin benefits from raw material cost relief, and its disciplined capital allocation should lead to above-trend earnings growth in 2025 through 2027, the analyst tells investors in a research note. The firm says to "buy quality when visibility is poor." ShowHide Related Items >><< - 04/30/23
- Fly Intel: Top five weekend stock stories
- 04/25/23
- Sherwin-Williams sees Q2 net sales up or down low-single digit %
- 04/19/23
- Sherwin-Williams to divest China paint business to Akzo Nobel N.V.
- 04/19/23
- Sherwin-Williams signs purchase agreement with Akzo Nobel N.V.
- 04/27/23 Deutsche Bank
- Sherwin-Williams price target raised to $265 from $260 at Deutsche Bank
- 04/27/23 Barclays
- Sherwin-Williams price target raised to $240 from $220 at Barclays
- 04/26/23 BMO Capital
- Sherwin-Williams price target raised to $253 from $231 at BMO Capital
- 04/26/23 Loop Capital
- Sherwin-Williams price target raised to $285 from $260 at Loop Capital
- 04/25/23
- Sherwin-Williams sees FY23 adjusted EPS $7.95-$8.65, consensus $8.48
- 04/25/23
- Sherwin-Williams reports Q1 adjusted EPS $2.04, consensus $1.78
- 04/24/23
- Notable companies reporting before tomorrow's open
- 04/30/23
- Goldman, Target among dividend growth stocks for slowing economy, Barron's says
- 02/08/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/26/23
- What You Missed On Wall Street On Thursday
- 01/26/23
- What You Missed On Wall Street This Morning
- 01/26/23
- Fly Intel: Pre-market Movers
|
Over a month ago |
Hot Stocks
|
Catch up on the… Catch up on the weekend's top five stories with this list compiled by The Fly: 1. Big banks including JPMorgan (JPM) and PNC Financial (PNC) submitted bids for First Republic Bank (FRC) to the Federal Deposit Insurance Corp., which is preparing to seize and sell the troubled lender, The Wall Street Journal's Andrew Ackerman, David Benoit, and Rachel Louise Ensign report, citing people familiar with the matter. The winning bidder could be announced later Sunday, the people said. 2. Astellas Pharma (ALPMY) and Iveric Bio (ISEE) announced that on April 29, 2023, the companies have entered into a definitive agreement under which Astellas through Berry Merger Sub, a wholly-owned subsidiary of Astellas US Holding, has agreed to acquire 100% of the outstanding shares of Iveric Bio for $40 per share in cash for a total equity value of approximately $5.9B. 3. After months of waiting, investors finally have an initial public offering worth buying. It's no highflying start-up, however. It's Kenvue, the consumer health spinoff from Johnson & Johnson (JNJ), and it looks like a winner, Andrew Bary writes in this week's edition of Barron's. Kenvue has a lot going for it. It owns such leading brands as Tylenol, Band-Aid, and Listerine; has a relatively cheap valuation; and will carry a dividend yield of more than 3.5% based on a planned quarterly payout of about 20 cents a share, the author notes. Backed by that pedigree, Kenvue (KVUE) plans to offer 151.2M shares-and possibly as many as 174 million shares at a price of $20 to $23 a share-late in the coming week. 4. Illumination and Universal's (CMCSA) Nintendo (NTDOY) video game adaptation "The Super Mario Bros. Movie" wins the weekend at the domestic box office with another $40M in its fifth weekend as the movie prepares to cross $1B at the worldwide box office to become only the 10th animated film to achieve such feat. Overseas, the film's projected weekend haul is $68.3M for a foreign tally of $532.5M. 5. Berkshire Hathaway (BRK.A; BRK.B), Thermo Fisher (TMO), Goldman Sachs (GS), Kroger (KR), Sherwin-Williams (SHW), Target (TGT), and UnitedHealth (UNH) saw positive mentions in this week's edition of Barron's. ShowHide Related Items >><< - $492.04 /
+1.515 (+0.31%) - 04/28/23
- Neuronetics announces expanded TMS access through United HealthCare
- 04/14/23
- UnitedHealth says Optum RX experienced another strong growth season
- 03/14/23
- Tactile Systems appoints Birkemeyer as Chief Financial Officer
- 03/09/23
- UNH recommended by Indiana to serve Medicaid beneficiaries who are 60+
- $554.86 /
+11.83 (+2.18%) - 04/24/23
- Thermo Fisher, Devyser Diagnostics enter NGS products distribution agreement
- 04/10/23
- PhenomeX appoints Silvester to board of directors
- 03/27/23
- Thermo Fisher opens cell therapy facility at UCSF
- 03/21/23
- Stevanato Group announces partnership with Thermo Fisher
- $157.77 /
-0.385 (-0.24%) - 03/14/23
- Target exec sells $5.56M in common stock
- 03/05/23
- Fly Intel: Top five weekend stock stories
- 02/28/23
- Target says 'Drive Up Returns' rolling out nationwide, starting this spring
- 02/28/23
- Target sees FY23 capital expenditures $4B-$5B
- 04/25/23
- Sherwin-Williams sees Q2 net sales up or down low-single digit %
- 04/19/23
- Sherwin-Williams to divest China paint business to Akzo Nobel N.V.
- 04/19/23
- Sherwin-Williams signs purchase agreement with Akzo Nobel N.V.
- 01/26/23
- Sherwin-Williams: 2023 base case remains to 'prepare for the worst'
- 04/14/23
- PNC Financial CFO sees reducing share repurchase activity in Q2
- 03/22/23
- PNC Financial raises prime lending rate to 8.00%, effective March 23
- 03/16/23
- First Republic confirms it will receive deposits totaling $30B from banks
- 03/16/23
- Fed, Treasury say banks' deposits in First Republic show system's 'resilience'
- 04/19/23
- March 2023 video game spending in U.S. fell 5% y/y, says Circana
- 04/19/23
- March 2023 video game spending fell 5% y/y, says Circana
- 04/12/23
- Alkaline Water earns nationwide distribution at Kroger
- 03/14/23
- Senate Democrats urge Walmart, Kroger, others to sell mifepristone
- 03/02/23
- Kroger says to invest more than $770M in associates in 2023
- 03/02/23
- Kroger sees FY23 CapEx $3.4B-$3.6B, free cash flow $2.3B-$2.5B, tax rate 23%
- 04/20/23
- JPMorgan announces replacement rate for securities linked to LIBOR ICE swap rate
- 04/16/23
- Fly Intel: Top five weekend stock stories
- 04/14/23
- JPMorgan rises 7.2%
- 04/14/23
- JPMorgan rises 6.9%
- 04/25/23
- Alkermes receives second interim award in Janssen arbitration
- 04/21/23
- J&J granted marketing authorization for Akeega in Europe
- 04/21/23
- MeiraGTx announces upcoming presentations at ARVO 2023 meeting
- 04/18/23
- Johnson & Johnson says procedures trending above pre-Covid levels
- 04/30/23
- Astellas to acquire Iveric Bio for $40 per share in cash
- 04/30/23
- Astellas to acquire Iveric Bio for $40 per share in cash
- 04/23/23
- Iveric bio announces findings from exploratory analyses of data for ACP
- 02/17/23
- Iveric bio rallies 23% to $24.70 after FDA approves Apellis drug
- 04/18/23
- Goldman Sachs sees pace of fundraising slowing for rest of year
- 04/18/23
- Goldman Sachs sees moderating repurchase levels in Q2 vs. Q1
- 04/18/23
- Goldman Sachs 'excited' to deepen partnership with Apple
- 04/18/23
- Goldman Sachs exploring sale of GreenSky
- 04/28/23
- First Republic drops 46% after Reuters reports FDIC receivership 'imminent'
- 04/28/23
- First Republic falls -50.1%
- 04/28/23
- First Republic halted again for volatility after dropping 50% to $3.09
- 04/28/23
- Barr says 'must strengthen' Fed supervision, regulation after Silicon Valley
- 04/09/23
- Fly Intel: Top five weekend stock stories
- 04/23/23
- Fly Intel: Top five weekend stock stories
- 04/23/23
- Comcast says NBCUniversal CEO Jeff Shell leaving company
- 04/11/23
- Comcast Business provides Oracle Park with WiFi 6E-ready network
- 12/19/22
- Berkshire Hathaway announces Thomas Murphy, Jr. elected to board of directors
- $500,639.00 /
+639 (+0.13%) - 04/25/23
- Berkshire Hathaway's NetJets sued by pilot's union
- 03/27/23
- Berkshire Hathaway acquires over 4.4M Occidental shares
- 03/16/23
- Berkshire Hathaway buys 7.9M shares of Occidental Petroleum for $466.68M
- 02/14/23
- Berkshire added more of top-holding Apple, Paramount in Q4
- 04/18/23 Credit Suisse
- JPMorgan price target raised to $160 from $155 at Credit Suisse
- 04/17/23 BMO Capital
- JPMorgan price target raised to $169 from $154 at BMO Capital
- 04/17/23 RBC Capital
- Large banks' earnings 'much better than expected', says RBC Capital
- 04/17/23 BofA
- JPMorgan price target raised to $158 from $152 at BofA
- 04/18/23 Credit Suisse
- PNC Financial price target lowered to $145 from $165 at Credit Suisse
- 04/17/23 Citi
- PNC Financial price target lowered to $150 from $175 at Citi
- 04/12/23 Barclays
- PNC Financial price target lowered to $167 from $218 at Barclays
- 04/26/23 Maxim
- First Republic cut to Hold at Maxim after deposit decline, balance sheet shrink
- 04/26/23 Maxim
- First Republic downgraded to Hold from Buy at Maxim
- 04/25/23 Credit Suisse
- First Republic price target lowered to $11 from $130 at Credit Suisse
- 04/25/23 Citi
- First Republic reinstated with Sell from Neutral at Citi
- 02/21/23 B. Riley
- Iveric bio price target raised to $19 from $17 at B. Riley
- 02/20/23 Wells Fargo
- Apellis rally on approval 'might fade,' says Wells Fargo
- 02/20/23 BofA
- Iveric now has 'clearer path towards approval,' says BofA
- 01/03/23 Wells Fargo
- Wells Fargo downgrades Apellis to Equal Weight, lowers price target to $58
- 04/26/23 Mizuho
- Alkermes arbitration award better than expected, says Mizuho
- 04/25/23 BMO Capital
- Legend Biotech price target raised to $90 from $79 at BMO Capital
- 04/24/23 Guggenheim
- Arcellx price target raised to $58 from $45 at Guggenheim
- 04/19/23 BTIG
- Legend Biotech price target raised to $85 from $75 at BTIG
- 04/28/23 Loop Capital
- Comcast price target raised to $50 from $46 at Loop Capital
- 04/28/23 UBS
- Comcast price target raised to $41 from $35 at UBS
- 04/28/23 Morgan Stanley
- Comcast price target raised to $48 from $45 at Morgan Stanley
- 04/28/23 KeyBanc
- Comcast price target raised to $46 from $44 at KeyBanc
- 09/27/22 Credit Suisse
- Charter price target lowered to $551 from $676 at Credit Suisse
- 09/27/22 Credit Suisse
- Comcast price target lowered to $51 from $57 at Credit Suisse
- 07/20/22 KeyBanc
- Disney price target lowered to $131 from $151 at KeyBanc
- 05/23/22 Raymond James
- Electronic Arts moves 'somewhat unexpected,' says Raymond James
- 02/27/23 Goldman Sachs
- Nintendo downgraded to Neutral from Buy at Goldman Sachs
- 02/24/23 Citi
- Nintendo downgraded to Neutral from Buy at Citi
- 01/27/23 Wedbush
- Nintendo assumed with an Outperform at Wedbush
- 01/11/23 JPMorgan
- Nintendo downgraded to Neutral from Overweight at JPMorgan
- $500,639.00 /
+639 (+0.13%) - 03/20/23
- After rumors, Gordon Haskett suggests Buffett could 'start at home' with Ally
- 02/26/23 Keefe Bruyette
- Berkshire price target lowered to $480,000 from $500,000 at Keefe Bruyette
- 02/07/23 UBS
- Berkshire can outperform given uncertain economy, says UBS
- 11/06/22 Keefe Bruyette
- Berkshire price target lowered to $495,000 from $500,000 at Keefe Bruyette
- 09/21/22 Edward Jones
- Berkshire Hathaway upgraded to Buy from Hold at Edward Jones
- 08/23/22
- Berkshire largest Celanese holder behind Vanguard, says Gordon Haskett
- 06/23/22 Truist
- Truist ups Occidental target to 'Street high' $93, sees good odds of Buffett bid
- 05/01/22 Keefe Bruyette
- Berkshire price target lowered to $560,000 from $565,000 at Keefe Bruyette
- $554.86 /
+11.83 (+2.18%) - 04/27/23 Citi
- Thermo Fisher price target lowered to $650 from $700 at Citi
- 04/27/23 Morgan Stanley
- Thermo Fisher price target lowered to $620 from $670 at Morgan Stanley
- 04/27/23 TD Cowen
- Thermo Fisher price target lowered to $693 from $711 at TD Cowen
- 04/27/23 Baird
- Thermo Fisher price target lowered to $670 from $693 at Baird
- 04/19/23 BMO Capital
- Goldman Sachs price target lowered to $414 from $429 at BMO Capital
- 04/19/23 Morgan Stanley
- Goldman Sachs price target raised to $337 from $329 at Morgan Stanley
- 04/19/23 RBC Capital
- Goldman Sachs price target raised to $375 from $339 at RBC Capital
- 04/19/23 JMP Securities
- Goldman Sachs price target raised to $470 from $460 at JMP Securities
- 04/25/23 Tigress Financial
- Albertsons upgraded to Buy from Neutral at Tigress Financial
- 04/12/23 BMO Capital
- Albertsons to remain in range pending Kroger deal clarity, says BMO Capital
- 03/20/23 Northcoast
- Kroger upgraded to Buy at Northcoast after Albertsons-fueled pullback
- 03/20/23 Northcoast
- Kroger upgraded to Buy from Neutral at Northcoast
- 04/27/23 Deutsche Bank
- Sherwin-Williams price target raised to $265 from $260 at Deutsche Bank
- 04/27/23 Barclays
- Sherwin-Williams price target raised to $240 from $220 at Barclays
- 04/26/23 BMO Capital
- Sherwin-Williams price target raised to $253 from $231 at BMO Capital
- 04/26/23 Loop Capital
- Sherwin-Williams price target raised to $285 from $260 at Loop Capital
- $157.77 /
-0.385 (-0.24%) - 04/24/23 Piper Sandler
- Bed Bath & Beyond Chapter 11 positive for Target, Walmart, says Piper Sandler
- 03/02/23 Roth MKM
- Target price target raised to $158 from $153 at Roth MKM
- 03/02/23 Evercore ISI
- Target removed from 'Tactical Underperform' list at Evercore ISI
- 03/01/23 Deutsche Bank
- Target price target raised to $165 from $143 at Deutsche Bank
- $492.04 /
+1.515 (+0.31%) - 04/20/23 Cantor Fitzgerald
- UnitedHealth initiated with an Overweight at Cantor Fitzgerald
- 04/17/23 Deutsche Bank
- UnitedHealth price target raised to $627 from $617 at Deutsche Bank
- 04/17/23 TD Cowen
- UnitedHealth price target lowered to $562 from $596 at TD Cowen
- 04/17/23 Loop Capital
- UnitedHealth price target raised to $600 from $590 at Loop Capital
- $492.04 /
+1.515 (+0.31%) - 04/14/23
- UnitedHealth raises FY23 adjusted EPS view to $24.50-$25.00 from $24.40-$24.90
- 04/14/23
- UnitedHealth reports Q1 adjusted EPS $6.26, consensus $6.13
- 01/13/23
- UnitedHealth backs FY23 adjusted EPS view $24.40-$24.90, consensus $24.94
- $554.86 /
+11.83 (+2.18%) - 04/26/23
- Thermo Fisher backs FY23 adjusted EPS view $23.70, consensus $23.71
- 04/26/23
- Thermo Fisher reports Q1 adjusted EPS $5.03, consensus $5.03
- 04/25/23
- Notable companies reporting before tomorrow's open
- $157.77 /
-0.385 (-0.24%) - 02/28/23
- Target sees FY23 adjusted EPS $7.75-$8.75, consensus $9.23
- 02/28/23
- Target sees Q1 adjusted EPS $1.50-$1.90, consensus $2.14
- 02/28/23
- Target reports Q4 adjusted EPS $1.89, consensus $1.40
- 02/27/23
- Notable companies reporting before tomorrow's open
- 04/25/23
- Sherwin-Williams sees FY23 adjusted EPS $7.95-$8.65, consensus $8.48
- 04/25/23
- Sherwin-Williams reports Q1 adjusted EPS $2.04, consensus $1.78
- 04/24/23
- Notable companies reporting before tomorrow's open
- 04/14/23
- PNC Financial sees FY23 revenue growth of 4%-5%, NII up 6%-8%
- 04/14/23
- PNC Financial sees Q2 revenue down 3% vs. Q1, consensus $5.66B
- 04/14/23
- PNC Financial sees FY23 revenue up 4%-5% vs. FY22, consensus $22.61B
- 04/14/23
- PNC Financial reports Q1 EPS $3.98, consensus $3.67
- 02/07/23
- Nintendo lowers FY23 revenue view Y1.6T from Y1.65T
- 02/07/23
- Nintendo reports 9M revenue Y1.3T vs. Y1.32T last year
- 11/08/22
- Nintendo raises FY23 revenue view Y1.65B from Y1.6B
- 11/08/22
- Nintendo reports 1H revenue Y656.9B vs. Y624.2B last year
- 03/02/23
- Kroger sees FY23 adjusted EPS $4.45-$4.60, consensus $4.20
- 03/02/23
- Kroger reports Q4 adjusted EPS 99c, consensus 89c
- 03/01/23
- Notable companies reporting before tomorrow's open
- 04/14/23
- JPMorgan reports Q1 EPS $4.10, consensus $3.41
- 04/13/23
- Notable companies reporting before tomorrow's open
- 01/13/23
- JPMorgan reports Q4 EPS $3.57, consensus $3.07
- 01/12/23
- Notable companies reporting before tomorrow's open
- 04/18/23
- Johnson & Johnson raises FY23 adjusted EPS to $10.60-$10.70 from $10.45-$10.65
- 04/18/23
- Johnson & Johnson reports Q1 adjusted EPS $2.68, consensus $2.51
- 04/17/23
- Notable companies reporting before tomorrow's open
- 02/28/23
- Fate Therapeutics reports Q4 EPS (58c), consensus (86c)
- 03/01/23
- Iveric bio reports Q4 EPS (47c), consensus (37c)
- 11/03/22
- Iveric bio reports Q3 EPS (35c), consensus (40c)
- 04/18/23
- Goldman Sachs reports Q1 EPS $8.79, consensus $8.10
- 01/17/23
- Goldman Sachs reports Q4 EPS $3.32, consensus $5.48
- 04/24/23
- First Republic reports Q1 EPS $1.23, consensus 85c
- 04/24/23
- Notable companies reporting after market close
- 01/13/23
- First Republic reports Q4 EPS $1.88, consensus $1.80
- 04/27/23
- Comcast reports Q1 adjusted EPS 92c, consensus 82c
- 04/26/23
- Notable companies reporting before tomorrow's open
- 01/26/23
- Comcast reports Q4 adjusted EPS 82c, consensus 77c
- 02/25/23
- Berkshire Hathaway reports Q4 operating earnings $6.71B vs. $7.29B last year
- $500,639.00 /
+639 (+0.13%) - 02/26/23
- Berkshire Hathaway Q4 operating earnings fall 8%, cash hoard tops $128B
- 11/05/22
- Berkshire Hathaway reports quarterly loss as operating earnings jump 20%
|
Periodicals
|
With economic growth… With economic growth slowing to an annualized pace of 1.1% in the first quarter, concerns of a recession are mounting, Lawrence Strauss writes in this week's edition of Barron's. None of this is news to the market, which has rewarded defensive sectors such as consumer staples with recent price gains. But there's another way to fortify your portfolio: owning stocks with dividends that can grow, the author says. A rising payout is usually a sign of business strength-something that becomes even more important in a slowing economy. According to Barron's, Goldman Sachs (GS), Kroger (KR), Sherwin-Williams (SHW), Target (TGT), and UnitedHealth (UNH) are five companies expected to hike payouts by double digits. Reference Link ShowHide Related Items >><< - $492.04 /
+1.515 (+0.31%) - 04/28/23
- Neuronetics announces expanded TMS access through United HealthCare
- 04/14/23
- UnitedHealth says Optum RX experienced another strong growth season
- 03/14/23
- Tactile Systems appoints Birkemeyer as Chief Financial Officer
- 03/09/23
- UNH recommended by Indiana to serve Medicaid beneficiaries who are 60+
- $157.77 /
-0.385 (-0.24%) - 03/14/23
- Target exec sells $5.56M in common stock
- 03/05/23
- Fly Intel: Top five weekend stock stories
- 02/28/23
- Target says 'Drive Up Returns' rolling out nationwide, starting this spring
- 02/28/23
- Target sees FY23 capital expenditures $4B-$5B
- 04/25/23
- Sherwin-Williams sees Q2 net sales up or down low-single digit %
- 04/19/23
- Sherwin-Williams to divest China paint business to Akzo Nobel N.V.
- 04/19/23
- Sherwin-Williams signs purchase agreement with Akzo Nobel N.V.
- 01/26/23
- Sherwin-Williams: 2023 base case remains to 'prepare for the worst'
- 04/12/23
- Alkaline Water earns nationwide distribution at Kroger
- 03/14/23
- Senate Democrats urge Walmart, Kroger, others to sell mifepristone
- 03/02/23
- Kroger says to invest more than $770M in associates in 2023
- 03/02/23
- Kroger sees FY23 CapEx $3.4B-$3.6B, free cash flow $2.3B-$2.5B, tax rate 23%
- 04/18/23
- Goldman Sachs sees pace of fundraising slowing for rest of year
- 04/18/23
- Goldman Sachs sees moderating repurchase levels in Q2 vs. Q1
- 04/18/23
- Goldman Sachs 'excited' to deepen partnership with Apple
- 04/18/23
- Goldman Sachs exploring sale of GreenSky
- 04/19/23 BMO Capital
- Goldman Sachs price target lowered to $414 from $429 at BMO Capital
- 04/19/23 Morgan Stanley
- Goldman Sachs price target raised to $337 from $329 at Morgan Stanley
- 04/19/23 RBC Capital
- Goldman Sachs price target raised to $375 from $339 at RBC Capital
- 04/19/23 JMP Securities
- Goldman Sachs price target raised to $470 from $460 at JMP Securities
- 04/25/23 Tigress Financial
- Albertsons upgraded to Buy from Neutral at Tigress Financial
- 04/12/23 BMO Capital
- Albertsons to remain in range pending Kroger deal clarity, says BMO Capital
- 03/20/23 Northcoast
- Kroger upgraded to Buy at Northcoast after Albertsons-fueled pullback
- 03/20/23 Northcoast
- Kroger upgraded to Buy from Neutral at Northcoast
- 04/27/23 Deutsche Bank
- Sherwin-Williams price target raised to $265 from $260 at Deutsche Bank
- 04/27/23 Barclays
- Sherwin-Williams price target raised to $240 from $220 at Barclays
- 04/26/23 BMO Capital
- Sherwin-Williams price target raised to $253 from $231 at BMO Capital
- 04/26/23 Loop Capital
- Sherwin-Williams price target raised to $285 from $260 at Loop Capital
- $157.77 /
-0.385 (-0.24%) - 04/24/23 Piper Sandler
- Bed Bath & Beyond Chapter 11 positive for Target, Walmart, says Piper Sandler
- 03/02/23 Roth MKM
- Target price target raised to $158 from $153 at Roth MKM
- 03/02/23 Evercore ISI
- Target removed from 'Tactical Underperform' list at Evercore ISI
- 03/01/23 Deutsche Bank
- Target price target raised to $165 from $143 at Deutsche Bank
- $492.04 /
+1.515 (+0.31%) - 04/20/23 Cantor Fitzgerald
- UnitedHealth initiated with an Overweight at Cantor Fitzgerald
- 04/17/23 Deutsche Bank
- UnitedHealth price target raised to $627 from $617 at Deutsche Bank
- 04/17/23 TD Cowen
- UnitedHealth price target lowered to $562 from $596 at TD Cowen
- 04/17/23 Loop Capital
- UnitedHealth price target raised to $600 from $590 at Loop Capital
- $492.04 /
+1.515 (+0.31%) - 04/14/23
- UnitedHealth raises FY23 adjusted EPS view to $24.50-$25.00 from $24.40-$24.90
- 04/14/23
- UnitedHealth reports Q1 adjusted EPS $6.26, consensus $6.13
- 04/13/23
- Notable companies reporting before tomorrow's open
- 01/13/23
- UnitedHealth backs FY23 adjusted EPS view $24.40-$24.90, consensus $24.94
- $157.77 /
-0.385 (-0.24%) - 02/28/23
- Target sees FY23 adjusted EPS $7.75-$8.75, consensus $9.23
- 02/28/23
- Target sees Q1 adjusted EPS $1.50-$1.90, consensus $2.14
- 02/28/23
- Target reports Q4 adjusted EPS $1.89, consensus $1.40
- 02/27/23
- Notable companies reporting before tomorrow's open
- 04/25/23
- Sherwin-Williams sees FY23 adjusted EPS $7.95-$8.65, consensus $8.48
- 04/25/23
- Sherwin-Williams reports Q1 adjusted EPS $2.04, consensus $1.78
- 04/24/23
- Notable companies reporting before tomorrow's open
- 03/02/23
- Kroger sees FY23 adjusted EPS $4.45-$4.60, consensus $4.20
- 03/02/23
- Kroger reports Q4 adjusted EPS 99c, consensus 89c
- 03/01/23
- Notable companies reporting before tomorrow's open
- 04/18/23
- Goldman Sachs reports Q1 EPS $8.79, consensus $8.10
- 04/17/23
- Notable companies reporting before tomorrow's open
- 01/17/23
- Goldman Sachs reports Q4 EPS $3.32, consensus $5.48
- $492.04 /
+1.515 (+0.31%) - 03/29/23
- UnitedHealth to reduce use of prior authorization process, Reuters reports
- 03/26/23
- Humana stock a bet on healthcare for seniors, Barron's says
- 03/21/23
- DOJ drops effort to block UnitedHealth's merger with Change, Law360 reports
- 12/05/22
- Citron goes short Agilon, says Supreme Court 'torpedoed' business
- $157.77 /
-0.385 (-0.24%) - 03/04/23
- Target 'a standout' among big box retailers, Barron's says
- 11/14/22
- Walmart taking 'aggressive' stance with suppliers, WSJ reports
- 02/02/23
- Beyond Meat revamps retail sales strategy around five grocers, WSJ says
- 01/18/23
- West Virginia reaches $83M opioid settlement with Walgreens, AP reports
- 12/20/22
- Walgreens, CVS limiting purchase of children's pain medications, Reuters reports
- 12/16/22
- PepsiCo tells Reuters it will launch 100 Tesla Semis in 2023
- 04/29/23
- SoftBank's Arm files confidentially for U.S. IPO, Reuters reports
- 04/06/23
- JPMorgan's Dimon sees recent banking turmoil boosting recession odds, CNN says
- 03/30/23
- White House calls for tougher rules on mid-sized banks, Bloomberg says
- 03/29/23
- FDIC may squeeze big banks to cover smaller bank failure costs, Bloomberg says
- $492.04 /
+1.515 (+0.31%) - 04/14/23
- What You Missed On Wall Street On Friday
- 04/14/23
- Fly Intel: Pre-market Movers
- 04/05/23
- What You Missed On Wall Street On Wednesday
- 04/05/23
- What You Missed On Wall Street This Morning
- $157.77 /
-0.385 (-0.24%) - 02/28/23
- What You Missed On Wall Street On Tuesday
- 02/28/23
- What You Missed On Wall Street This Morning
- 02/28/23
- Fly Intel: Pre-market Movers
- 02/27/23
- Here's what Wall Street experts are saying about Target ahead of earnings
- 02/08/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/26/23
- What You Missed On Wall Street On Thursday
- 01/26/23
- What You Missed On Wall Street This Morning
- 01/26/23
- Fly Intel: Pre-market Movers
- 03/20/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 02/04/23
- Buy/Sell: Wall Street's top 10 stock calls this week
- 01/17/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 12/21/22
- What You Missed On Wall Street On Wednesday
- 04/18/23
- What You Missed On Wall Street On Tuesday
- 04/18/23
- What You Missed On Wall Street This Morning
- 04/18/23
- Fly Intel: Pre-market Movers
- 04/17/23
- Here's what Wall St. experts are saying about these banks ahead of earnings
- $492.04 /
+1.515 (+0.31%) - 04/05/23
- Unusually active option classes on open April 5th
- 02/17/23
- Early notable gainers among liquid option names on February 17th
- 01/18/23
- Unusually active option classes on open January 18th
- $157.77 /
-0.385 (-0.24%) - 04/28/23
- Unusually active option classes on open April 28th
- 04/21/23
- Unusually active option classes on open April 21st
- 02/28/23
- Early notable gainers among liquid option names on February 28th
- 02/28/23
- Unusually active option classes on open February 28th
- 04/28/23
- Kroger put volume heavy and directionally bearish
- 04/04/23
- Kroger put volume heavy and directionally bearish
- 04/04/23
- Unusually active option classes on open April 4th
- 03/02/23
- Early notable gainers among liquid option names on March 2nd
- 04/18/23
- Unusually active option classes on open April 18th
- 04/14/23
- Unusually active option classes on open April 14th
- 03/09/23
- World Low Volatility ETF put volume heavy and directionally bearish
- 01/17/23
- Unusually active option classes on open January 17th
|
Recommendations
|
Deutsche Bank raised the… Deutsche Bank raised the firm's price target on Sherwin-Williams to $265 from $260 and keeps a Buy rating on the shares. The analyst says the company is regaining momentum. ShowHide Related Items >><< - 04/25/23
- Sherwin-Williams sees Q2 net sales up or down low-single digit %
- 04/19/23
- Sherwin-Williams to divest China paint business to Akzo Nobel N.V.
- 04/19/23
- Sherwin-Williams signs purchase agreement with Akzo Nobel N.V.
- 01/26/23
- Sherwin-Williams: 2023 base case remains to 'prepare for the worst'
- 04/27/23 Barclays
- Sherwin-Williams price target raised to $240 from $220 at Barclays
- 04/26/23 BMO Capital
- Sherwin-Williams price target raised to $253 from $231 at BMO Capital
- 04/26/23 Loop Capital
- Sherwin-Williams price target raised to $285 from $260 at Loop Capital
- 04/26/23 Mizuho
- Sherwin-Williams price target raised to $268 from $263 at Mizuho
- 04/25/23
- Sherwin-Williams sees FY23 adjusted EPS $7.95-$8.65, consensus $8.48
- 04/25/23
- Sherwin-Williams reports Q1 adjusted EPS $2.04, consensus $1.78
- 04/24/23
- Notable companies reporting before tomorrow's open
- 02/08/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/26/23
- What You Missed On Wall Street On Thursday
- 01/26/23
- What You Missed On Wall Street This Morning
- 01/26/23
- Fly Intel: Pre-market Movers
|
Recommendations
|
Barclays raised the… Barclays raised the firm's price target on Sherwin-Williams to $240 from $220 and keeps an Equal Weight rating on the shares post the Q1 results. Sherwin started the year strong, outperforming on sales and reinforcing investor belief that the fiscal year guidance is conservative, the analyst tells investors in a research note. ShowHide Related Items >><< - 04/25/23
- Sherwin-Williams sees Q2 net sales up or down low-single digit %
- 04/19/23
- Sherwin-Williams to divest China paint business to Akzo Nobel N.V.
- 04/19/23
- Sherwin-Williams signs purchase agreement with Akzo Nobel N.V.
- 01/26/23
- Sherwin-Williams: 2023 base case remains to 'prepare for the worst'
- 04/26/23 BMO Capital
- Sherwin-Williams price target raised to $253 from $231 at BMO Capital
- 04/26/23 Loop Capital
- Sherwin-Williams price target raised to $285 from $260 at Loop Capital
- 04/26/23 Mizuho
- Sherwin-Williams price target raised to $268 from $263 at Mizuho
- 04/19/23 Mizuho
- Sherwin-Williams price target raised to $263 from $255 at Mizuho
- 04/25/23
- Sherwin-Williams sees FY23 adjusted EPS $7.95-$8.65, consensus $8.48
- 04/25/23
- Sherwin-Williams reports Q1 adjusted EPS $2.04, consensus $1.78
- 04/24/23
- Notable companies reporting before tomorrow's open
- 02/08/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/26/23
- What You Missed On Wall Street On Thursday
- 01/26/23
- What You Missed On Wall Street This Morning
- 01/26/23
- Fly Intel: Pre-market Movers
|
Recommendations
|
BMO Capital analyst John… BMO Capital analyst John McNulty raised the firm's price target on Sherwin-Williams to $253 from $231 but keeps a Market Perform rating on the shares. The company posted a "solid" Q1 earnings beat with raw material costs finally starting to slide and its end-markets holding up relatively well in spite of a soft macro backdrop, the analyst tells investors in a research note. BMO add however that Sherwin-Williams looks relatively fairly valued, and it would wait for a pullback to get more constructive on the name. ShowHide Related Items >><< - $234.80 /
-1.955 (-0.83%) - 04/25/23
- Sherwin-Williams sees Q2 net sales up or down low-single digit %
- 04/19/23
- Sherwin-Williams to divest China paint business to Akzo Nobel N.V.
- 04/19/23
- Sherwin-Williams signs purchase agreement with Akzo Nobel N.V.
- 01/26/23
- Sherwin-Williams: 2023 base case remains to 'prepare for the worst'
- $234.80 /
-1.955 (-0.83%) - 04/26/23 Loop Capital
- Sherwin-Williams price target raised to $285 from $260 at Loop Capital
- 04/26/23 Mizuho
- Sherwin-Williams price target raised to $268 from $263 at Mizuho
- 04/19/23 Mizuho
- Sherwin-Williams price target raised to $263 from $255 at Mizuho
- 04/13/23 Deutsche Bank
- Sherwin-Williams named short-term buy idea at Deutsche Bank
- $234.80 /
-1.955 (-0.83%) - 04/25/23
- Sherwin-Williams sees FY23 adjusted EPS $7.95-$8.65, consensus $8.48
- 04/25/23
- Sherwin-Williams reports Q1 adjusted EPS $2.04, consensus $1.78
- 04/24/23
- Notable companies reporting before tomorrow's open
- $234.80 /
-1.955 (-0.83%) - 02/08/23
- Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
- 01/26/23
- What You Missed On Wall Street On Thursday
- 01/26/23
- What You Missed On Wall Street This Morning
- 01/26/23
- Fly Intel: Pre-market Movers
|